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Depression
In the Netherlands, major depressive disorder (MDD) affects an estimated 15.4% of individuals 
during their lifetime (Bijl et al., 1998). This number is comparable with the reported lifetime 
prevalence of MDD in the United States, which is 16.2% (Kessler et al., 2003). The impact 
of depression on the individual and society is as big as that of common medical illnesses 
(Merikangas et al., 2007), making it an important target of research over the past decades. This 
research has resulted in extensive knowledge about the disease and how to treat it. However, 
this knowledge is still far from complete. For example, 50% of depressed patients react only 
partially or even not at all to antidepressant treatment (Souery et al., 2006). Moreover, about 
one third of depressed patients will in time become resistant to treatment (Fava and Davidson, 
1996). One explanation for this hiatus may be that depression is a very heterogeneous disease. 
To be diagnosed with MDD, an individual has to fulfill five of the eleven criteria of a major 
depressive episode, as stated by the Diagnostic and Statistical Manual of Mental Disorders-IV 
(DSM-IV; American Psychiatric Association, 2001) (Table 1.) (The studies described in this 
thesis were all conducted before the introduction of DSM 5 in 2013).
Thus, theoretically, two patients can be diagnosed with MDD based on two entirely different 
symptom profiles. Identifying certain subtypes of MDD could contribute to differentiation 
and specification of treatment strategies, improving an individuals’ likelihood of treatment-
response and as such improving chances of remission (Wong and Licinio, 2001).
Subtypes of depression
At the end of the 19th century, Paul Julius Möbius further developed Morel’s (1857; as cited 
in Mendels and Cochrane, 1968) theory of distinction between exogenous (caused by the 
environment) and endogenous (caused by heredity) psychiatric disorders (Möbius, 1893 as 
cited in Beer, 1996). This in turn inspired Kraepelin’s dichotomization of endogenous depression 
(or ‘manic-depressive psychosis’) and exogenous or reactive depression (Kraepelin, 1913). In 
a review of seven studies that used factor analysis, Mendels and Cochrane (1968) confirmed 
the independence of endogenous and reactive factors, but proposed an alternative take on this 
dichotomy; the endogenous factor may represent a ‘classical’ depressive syndrome, whereas the 
reactive factor may reflect a (group of) psychiatric disorders where depression is only one of 
the symptoms (Mendels and Cochrane, 1968). In the early 70s of the 20th century, Akiskal and 
McKinney argued for the unification of these two types of depression, stating that depressive 
illness should be seen as the result of several processes that interact in brain areas associated 
with e.g. arousal, mood and motivation. These processes can be influenced genetically, 
developmentally, psychosocially, physiologically or by personality traits, eventually resulting 
in biochemical alterations, of which depression is one of the possible outcomes (Akiskal and 
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Table 1
DSM-IV criteria for Major Depressive Episode
A. Five (or more) of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning; at least one of the symptoms is 
either (1) depressed mood or (2) loss of interest or pleasure.
(1) Depressed mood most of the day, nearly every day, as indicated by either subjective report 
(e.g. feels sad or empty) or observation made by others (e.g. appears tearful).
(2) Markedly diminished interest or pleasure in all, or almost all, activities most of the day, 
nearly every day (as indicated by either subjective account or observation made by 
others).
(3) Significant weight loss when not dieting or weight gain (e.g. a change of more than 5% of 
body weight in a month), or increase or decrease in appetite nearly every day.
(4) Insomnia or hypersomnia nearly every day.
(5) Psychomotor agitation or retardation nearly every day (observable by others, not merely 
subjective feelings of restlessness or being slowed down).
(6) Fatigue or loss of energy nearly every day.
(7) Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick).
(8) Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by 
subjective account or as observed by others).
(9) Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide.
B. The symptoms cause clinically significant distress or impairment in social, occupational, 
or other important areas of functioning.
C. The symptoms are not due to the direct psychological effects of a substance (e.g. a drug of 
abuse, a medication) or a general medical condition.
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Mckinney, 1973, 1975). Shortly thereafter, in 1980, the unitarian model of depression was 
recorded in the newest version of the DSM-III (American Psychiatric Association, 1980). Not 
only etiologically is the distinction between endogenous and exogenous depression untenable, 
another difficulty is the notion that depressive disorder is a highly recurrent disorder. The 
risk of recurrence of depression increases from 50% after one’s first episode to 80% after 2 or 
more episodes (Kupfer et al., 1996, Post, 1992). This suggests that even though a depression 
may initially be initiated by adverse life events, therefore being classified as exogenous, its 
occurrence then increases the risk of recurrence without further life events, turning into 
endogenous depression.
Besides diagnostic criteria, the DSM-IV describes three levels of classification of MDE: first, 
the clinical status of the current (or in case of (partial) remission most recent) depressive 
episode is defined. Besides level of remission (current episode, partly remitted, or fully 
remitted), description of the clinical status includes severity (mild, moderate, or severe). 
Severe depression can be further classified by absence or presence of psychotic symptoms. 
A second level of definition used by the DSM-IV-TR is based on the course of the disorder 
(the ‘chronicity specifier’) or on specific symptoms (catatonic features, melancholic features, 
atypical features, and postpartum onset). The third classification of depressive episodes 
according to the DSM-IV-TR is based on the characteristics of recurring episodes (longitudinal 
course specifiers and seasonal pattern).
Thus, in the DSM-IV, a subtype of depression is based on behavioral and course characteristics 
of depressive episodes. Other factors that may influence course and treatment success of the 
disease like gene polymorphisms or biomarkers are not considered.
Depression and anger regulation problems
Anger regulation problems, ranging from irritability and hostility to verbal and/or physical 
aggression, e.g. in the form of anger attacks, have long been associated with depression. This 
recognition dates back as far as Kraepelin, who already recognized the occurrence of anger as 
a symptom of depression (Kraepelin, 1883). According to Kraepelin, when the inner tension 
that comes with depression can no longer be restrained, release will be found in an uncontrolled 
act of aggression. This act can be directed towards oneself, resulting in suicide. When the 
fear of dying is too great, however, release can be sought in an act of aggression directed at 
others, even resulting in murder. Freud also recognized the concept of anger in the context 
of depression. He saw anger as something that could not only be expressed outwards, but can 
also turn inwards, resulting in depression (Freud, 1917). More recently, Van Praag suggested 
that aggression is one of the core symptoms of depression caused by 5-HT disturbance, and 
mood lowering is only a secondary symptom (Van Praag, 1992). Moreover, studies by Fava et 
al. confirmed that 30 to 40% of depressed patients report anger attacks (Fava and Rosenbaum, 
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1998, 1999). Moreover, irritable mood is considered a core symptom of depression in children 
and adolescents (American Psychiatric Association, 2001). However, in adult patients with 
depression, it is not part of the diagnostic criteria, despite the fact that about 30-40% of adult 
patients report symptoms of irritability and anger (Fava et al., 2009, Fava and Rosenbaum, 
1999, Perlis et al., 2009, Fava and Rosenbaum, 1998). Antidepressant medication has been 
used successfully to reduce these symptoms (Van Praag, 2001, Katz et al., 1987).
In the early 90s of the 20th century, Van Praag proposed a subtype of depression which he called 
‘Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression’ (Van Praag, 
1996). The primary symptoms of this subtype were not sadness and anhedonia, but anxiety 
and aggression. Evidence for this subtype came mainly from association studies, for example 
from a study showing higher anxiety scores for depressed patients with lower concentrations 
of the metabolite 5-Hydroxyindoleacetic acid (5-HIAA) which indicates lowered serotonin 
(or 5-hydroxytryptamine – 5-HT) turnover (Van Praag, 1998). The theoretical background of 
this subtype however remained rather unclear. An undefined combination of biological and 
psychological predisposition or impairment results in susceptibility to stress which in turn 
can cause increased risk of anxiety and suppressed anger, eventually resulting in depression 
(Van Praag, 1998, 1996).
Fava et al. investigated the differences between depressed patients with and without anger 
attacks (Fava et al., 1997, Fava and Rosenbaum, 1999, Fava et al., 1993). Anger attacks were 
defined as: ‘sudden spells of anger accompanied by symptoms of autonomic activation such 
as tachycardia, sweating, hot flashes, and tightness of the chest which resembles panic attacks 
but without the predominant affects of fear and anxiety’ (Fava and Rosenbaum, 1998). 
Depressed patients with anger attacks were found to differ from depressed patients without 
anger attacks, for example in their clinical profiles. Specifically, depressed patients with anger 
attacks had higher levels of hostility and anxiety (Fava et al., 1993) and more comorbid axis II 
psychopathology (Tedlow et al., 1999) compared to depressed patients without anger attacks. 
Physiological differences were also observed between these patient groups, with depressed 
patients with anger attacks having higher cholesterol levels and an increased risk of cardiac 
dysfunction (Fraguas et al., 2007) compared to depressed patients without anger attacks.
A milder form of anger regulation problems in depression -irritability- was also found to 
be present in about 40% of depressed patients (Fava et al., 2009, Perlis et al., 2009). These 
irritable depressed patients reported an ‘irritable, grouchy or […] bad mood almost every day 
during the worst two weeks of the index [depressive] episode’ (Fava et al., 2009). Comparing 
depressed patients with and without irritability, those with irritability had a higher number of 
aggression-related axis II disorders (Fava et al., 2009), reported symptoms of dysthymia more 
often (Perlis et al., 2009), and had a greater prevalence of comorbid anxiety disorders (Fava et 
al., 2009, Perlis et al., 2009). Irritable depressed patients had also more often attempted suicide 
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(Perlis et al., 2009) than depressed patients who were not irritable during their depression. 
Based on the aforementioned studies, anger attacks and irritability might be characteristics to 
distinguish different types of depression from each other.
Factors contributing to depression & anger/aggression
Maladaptive behavioral patterns such as depression and aggression generally do not have one 
specific cause. Rather, numerous factors can contribute to the onset and relapse of depression 
and aggression, and some, if not all of them might interact. Literature on factors associated 
with depression and aggression is further discussed below.
Serotonin
An important aspect of depression is its association with 5-HT; more specifically, impairments 
of the 5-HT system have been found relatively consistently in depression (Maes and Meltzer, 
1995). Animal models (Sanchez and Meier, 1997), post-mortem studies in suicide victims 
(Åsberg et al., 1976) as well as the beneficial effect of serotonin reuptake inhibitors (SSRI’s) 
in large numbers of depressed patients (Trivedi et al., 2006, Willner et al., 2013) support this 
hypothesis.
The first studies to investigate 5-HT neurotransmission in depression experimentally included 
so-called 5-HT neuroendocrine challenge tests. An example of such a neuro-endocrine 
challenge test that was commonly used up to the late 1990s, included the administration of 
thyrotropin releasing hormone (TRH) or DL-fenfluramine hydrochloride (Jans et al., 2006). 
5-HT inhibits the release of thyrotropin releasing hormone (TRH), a hormone that normally 
stimulates the release of prolactin. Fenfluramine is a 5-HT releasing agent and re-uptake 
inhibitor (Mcbride et al., 1990) which increases plasma prolactin in healthy volunteers (Cowen, 
1993) through the activation of 5-HT2a/2c receptors. Compared to depressed patients without 
anger attacks, depressed patients with anger attacks showed blunted prolactin response to 
both TRH and fenfluramine (Fava et al., 2000, Rosenbaum et al., 1993), as well as an increased 
response to the selective serotonergic reuptake inhibitor (SSRI) fluoxetine (Rosenbaum et al., 
1993). Another study with fluoxetine reports no significant differences in the improvement 
of depressive symptoms after fluoxetine intake between depressed patients with anger attacks 
and depressed patients without anger attacks (Fava et al., 1993).The only study to investigate 
the use of antidepressant medication as a treatment of anger attacks found that sertraline (an 
SSRI) and imipramine (a tricyclic antidepressant or TCA) were more effective than placebo 
in reducing the anger attacks in depressed patients (Fava et al., 1997).





























Figure 1. Acute Tryptophan Depletion (ATD)
Normally free tryptophan (Trp) is transported through the blood brain barrier (BBB), as are 
other large neutral amino acids (LNAAs), after which it is converted via 5-hydrxytryptophan 
(5-HTP) into serotonin (5-HT). ATD consists of LNAAs without the addition of Trp, 
resulting in increased competition at the BBB, resulting in less available free Trp in the 
brain and subsequently lower levels of 5-HT.
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Acute tryptophan depletion
While the 5-HT hypothesis of depression in its original formulation postulated 5-HT 
impairments as the cause of depression, this hypothesis has been refined over the years (Booij 
et al., 2013). One specific procedure that has been used extensively to investigate the role 
of 5-HT in depression, and in fact contributed to the refinement of the 5-HT hypothesis 
of depression, is acute tryptophan depletion (ATD). This method temporarily lowers the 
precursor of 5-HT, the amino acid L-tryptophan (Trp) in the brain (Young et al., 1985, Van 
der Does, 2001) (Figure 1). Normally, Trp is taken up from the blood. Most of the Trp in 
the blood is protein-bound, but the 5% that is not is called free Trp which is transported 
across the blood-brain barrier, where it competes with five other large neutral amino acids 
(LNAA’s: valine, leucine, isoleucine, phenylalanine and tyrosine) (Young et al., 1985). In the 
brain, Trp is converted into 5-HT. ATD in humans consists of the intake of a mixture of 
LNAA’s. These LNAA’s promote protein synthesis and compete with Trp at the blood-brain 
barrier, eventually causing decreased Trp levels in the brain, which in turn causes lowering 
of 5-HT synthesis. ATD therefore allows the investigation of the causal effects of lowered 
serotonin neurotransmission on human behavior in a controlled experimental design (Young 
et al., 1985).
Numerous studies have investigated the effects of this transient lowering of 5-HT on 
depressed mood. The first ATD studies in depression showed that remitted depressed patients 
using SSRIs have a greater increase in depressive symptoms in response to ATD than those 
using monoamine oxidase inhibitors or TCAs (Delgado et al., 1990, Delgado et al., 1999). 
Participants who were recovered and symptom-free (Smith et al., 1997) showed an increase in 
depressive symptoms in reaction to ATD relative to placebo, as did healthy individuals with an 
extensive family history of depression (Benkelfat et al., 1994). In currently depressed patients, 
no immediate effect of ATD on depressive symptoms was found (Delgado et al., 1994, Booij 
et al., 2005,). Moreover, in remitted/recovered depressed patients, a greater response to ATD 
has been associated with recurrent past episodes, female gender, history of suicidal ideation 
(Booij et al., 2002), certain genotypes of specific 5-HT genes (Neumeister et al., 2006) and 
impaired 5-HT2A receptor function (Yatham et al., 2012). These studies, in combination with 
other challenge studies in vulnerable populations (e.g. Bhagwagar et al., 2002) suggest that 
impaired 5-HT function in depression might be an indication of someone’s vulnerability to 
depression rather than a direct cause of depression (Booij et al., 2003, Willner et al., 2013, 
Booij et al., 2013).
5-HT and aggression 
In addition to vulnerability to depression, impaired 5-HTergic function has also been 
associated with a range of vulnerability to aggression-related behaviors, such as impulsive 
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and violent criminal behavior (Marsh et al., 2002), suicide attempts (Åsberg et al., 1976), 
physical aggression (Booij et al., 2010), and completed suicides (Träskman-Bendz and Mann, 
2001). Cleare and Bond (1995) found increased anger, aggression, annoyance and hostility 
after ATD in healthy males with high trait aggression compared to healthy males with low 
trait aggression.
Antidepressant treatment and aggression
The Multidisciplinary Guideline for Depression (MDRL; Spijker et al., 2013) provides 
recommendations and instructions of operation for use in daily practice of mental health 
care for depression in adults. When the use of antidepressant medication is indicated, e.g. for 
moderate to severe depression and depression with melancholic or psychotic symptoms, the 
MDRL recommends the use of SSRIs for all outpatients. Anderson et al. (1998, 2000) showed 
that TCAs were only more effective compared to SSRIs in inpatients, which is however not 
necessarily related to depression severity (Anderson, 2000).
The SSRI fluoxetine has also been shown to reduce irritability and aggression scores in patients 
with personality disorder (Coccaro and Kavoussi, 1997). Together with recommendations 
from previous studies on anger regulation problems in depression (Van Praag, 2001, Katz 
et al., 1987, Fava et al., 1993, Rosenbaum et al., 1993) it seems for depression with anger 
regulation problems SSRIs may be preferable.
Figure 2 is based on the MDRL and shows the potential use of anger regulation problems 
in diagnostic decisions for treatment of depression. In line with the ‘profiling’ concept to 
identify characteristics that influence the course of depression and/or treatment outcome, 
anger regulation problems may have a place in diagnostic and treatment related decisions.
Cognition
In addition to depressed mood, and symptoms of irritability, anger and/or aggression in 
some subgroups of depressed patients, cognitive impairments often occur in depression. 
Concentration and memory problems are part of the diagnostic criteria of MDD (DSM-
IV; American Psychiatric Association, 2001). Moreover, it has been shown that depressed 
patients show a bias towards negative information in various emotion processing tasks (Gur 
et al., 1992, Burt et al., 1995, Bouhuys et al., 1999, Elliott et al., 2011, Gotlib and Mccann, 1984, 
Gollan et al., 2008, Mikhailova et al., 1996, Segal et al., 1995, Surguladze et al., 2004). This bias 
might persist after remission from depression (Bhagwagar et al., 2004, de Raedt and Koster, 
2010, Hayward et al., 2005, Joormann and Gotlib, 2007). Merens et al. (2008b) found some 
persisting bias for emotional stimuli such as fearful faces in a sample of remitted depressed 
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patients. However, their study suggests that most biases found during the depression may 
have become latent after remission, and will only be activated after being triggered, for 
example by ATD. Studies using this technique found evidence for a causal role of 5-HT in 
these emotional biases in both healthy volunteers (Munafò et al., 2006, Elliott et al., 2011) and 
remitted/recovered depressed patients (Hayward et al., 2005, Booij et al., 2005, Merens et al., 
2008a).
Depressed patients often have dysfunctional cognitive schemas (Beck, 1967), with thoughts 
such as ‘People will probably think less of me if I make a mistake’ (Weissman, 1980, Weissman 
and Beck, 1978). These so-called dysfunctional attitudes merely become inactive instead 
of actually disappearing during remission (Teasdale, 1988). The ease, with which these 
latent dysfunctional schemas are reactivated in response to sad mood, is called cognitive 
reactivity (Segal et al., 1999). Several studies have shown that remitted depressed patients 
have significantly higher cognitive reactivity levels than never-depressed healthy individuals 
(Miranda and Persons, 1988, Van Der Does, 2002, de Raedt and Koster, 2010). High levels of 
cognitive reactivity predicted relapse to depression within four years after treatment (Segal 
et al., 1999). Moreover, in remitted depressed patients, a greater mood response to ATD was 
associated with greater cognitive reactivity (Booij and Van Der Does, 2007), thereby showing 
a possible link between cognitive and 5-HT vulnerability.
Psychophysiology
Several changes in neuroendocrine measures have been associated with depression and 
aggression/anger. For example, increases in testosterone and cortisol have been associated 
with aggression (Harris, 1999, Van Bokhoven et al., 2005). Anger problems in MDD have also 
been associated with increased cortisol levels (Van Praag, 2002, Van Praag, 1996a). Moreover, 
increased testosterone has frequently been linked to anger and aggression regulation (Persky 
et al., 1971, Van Honk et al., 1999, Archer, 2006, Mehta and Beer, 2009).
Both cortisol and testosterone have been shown to interact intensively with the 5-HT system 
(Cowen, 2002, Strickland et al., 2002, Way and Taylor, 2010, Kuepper et al., 2010, Montoya 
et al., 2012). On the other hand, diminished testosterone levels have been found in female 
depressed patients (Giltay et al., 2012). Moreover, patients using SSRIs had higher levels of 
testosterone than those not using SSRIs (Giltay et al., 2012). Administration of testosterone 
has been suggested to have antidepressant effects in some patients such as older depressed 
males (Zarrouf et al., 2009). However, randomized controlled trials are lacking.
Depressed patients are more vulnerable to cardiovascular disease (CVD) than non-depressed 
individuals (Joynt et al., 2003). Lowered heart rate variability (HRV) has been identified as a 
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possible risk factor for CVD and several studies did find lowered HRV in depressed patients 
(Agelink et al., 2002, Rechlin et al., 1994). Moreover, in a study which compared remitted 
depressed patients who reported suicidal ideation during their depression with remitted 
depressed patients without previous suicidal ideation, Booij et al. (2006) found that ATD 
significantly lowered HRV in remitted depressed with previous suicidality but not in those 
without. This suggests that depressed patients with previous suicidal ideation may have an 
increased risk of CVD which is possibly associated with increased 5-HTergic vulnerability 
(Booij et al., 2006).
Another CVD risk factor associated with depression, suicide and aggression is cholesterol 
levels. Lowered serum cholesterol was found for MDD patients compared to healthy controls 
(Olusi and Fido, 1996, Lehto et al., 2008, Steegmans et al., 2000, Shin et al., 2008) as well 
as in suicide attempters compared to nonsuicidal psychiatric patients (Kunugi et al., 1997, 
Troisi, 2009). A study by Buydens-Branchey et al. (2000) suggested that the link they found 
between lowered cholesterol and poor impulse-control and aggression may be associated with 
alterations in 5-HT function.
In sum, several neuroendocrine and psychophysiological indices are associated with 
depression and aggression, and all of those measures have to some extent been associated 
with 5-HTergic functioning.
Heritability
Depression is known to occur more frequently in individuals with a family history of 
depression (Kendler et al., 1997, Sullivan et al., 1996, Sullivan et al., 2000) compared to 
those without a family history of depression. Comparing monozygotic and dizygotic twins 
and adoption studies have enabled us to disentangle the role of genetic and environmental 
influences on the development of psychopathology. Several longitudinal twin studies have 
found moderate heritability rates of depression of 42% in women and 29% in men (Kendler et 
al., 2006, Kendler et al., 2001, Bierut et al., 1999, Jansson et al., 2004).
Candidate gene studies have been done in an attempt to identify specific genes involved in 
depression. Many of these are linked to the 5-HT system, although many other genes of other 
biological systems have been identified, and all of them might interact (Lesch, 2004). Below 
is a description of the most commonly studied candidate genes in the context of depression, 
aggression and suicidality.
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5-HT transporter gene (SLC6A4)
Probably the most widely investigated polymorphism in psychiatry is the 5-HT transporter 
(5-HTT) linked polymorphic region (5-HTTLPR) of the SLC6A4 gene (Risch et al., 2009, 
Lesch, 2004) and its association with depression. Function of SLC6A4, involved in 5-HT 
uptake in the brain, is known to be altered in several disorders e.g. depression, as well as 
bipolar disorder and schizophrenia (Heils et al., 1996). SLC6A4 is also a prime target for 
antidepressant action (Heils et al., 1996). The most commonly investigated polymorphism 
of the 5-HT transporter, 5-HTTLPR, has two variants. The short allele (s) variant results in 
reduced transcriptional efficiency compared to the long allele (l). More recently, another 
polymorphism (rs25531) has been described (Wendland et al., 2006). This G allele in the l 
variant of the polymorphism is functionally similar to the s allele, with lower 5-HTT mRNA 
expression (Hu et al., 2006). Carriers of at least one s allele have a higher risk of depression 
and increased anxiety-related traits (Lesch et al., 1996a) compared to homozygote long allele 
carriers (ll). Comparing depressed and non-depressed women, Gonda et al. (2011) found an 
association between the s allele and aggression/hostility, which was even more marked in the 
presence of depression. One psychological concept extensively studied in relation to depression 
is neuroticism: the tendency to more easily experience negative emotions, including feelings 
of depression, anxiety and anger (Matthews et al., 2003). Lesch et al. found increased levels of 
anxiety associated with the s allele (Lesch et al., 1996b). In another study in healthy women, 
the s allele was associated with traits and characteristics related to the concept of neuroticism, 
e.g. anxiety, depression, hopelessness and hostility (Gonda et al., 2009).
However, the findings are not consistent. As Levinson (2006) already pointed out, the positive 
associations between depression and 5-HTTLPR found by previous studies are mostly small 
and indirect. The meta-analysis by Karg et al. (2011) found evidence of increased stress 
sensitivity in association with the s allele of the 5-HTTLPR polymorphism, whereas two 
meta-analyses by Munafò et al. (2009) and Risch et al. (2009) found no such association. The 
inconsistency between these studies may partly be explained by methodological differences 
between studies used in these meta-analyses (Uher et al., 2010). 
5-HT1A receptor gene
The 5-HT1A receptor is a 5-HTergic autoreceptor in the raphe; it is also expressed post-
synaptically in other brain-regions. It is involved in the regulation of 5-HT transmission by 
reduction of firing rate through negative feedback; one relatively common variant (Wu and 
Comings, 1999) of this receptor (C-1019G) has been shown to lead to a decrease in 5-HT 
transmission (Lemonde et al., 2003, Neumeister et al., 2004) and has been linked to major 
depression and suicide to (Lemonde et al., 2003, Kishi et al., 2013). Although the observation 
of the relationship between the G-allele of the 5- HT1A C(-1019G) gene and MDD has been 
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replicated (e.g. Albert et al., 2011), findings have not been entirely consistent (e.g. Arias et al., 
2002), as is the case for all other candidate gene studies in MDD.
Tryptophan hydroxylase 
Tryptophan hydroxylase (TPH) is a rate-limiting enzyme which is critical for the biosynthesis 
of 5-HT – converting the amino acid Trp to 5-hydroxytryptophan (5-HT) which in turn is 
decarboxylated into 5-HT (Bondy et al., 2006). Two forms of TPH exist; TPH1 is found mainly 
peripherally, whereas another variant (now called TPH2) is found only in the brain (Zhang 
et al., 2004). One study showed that genotypic variation in several TPH2 polymorphisms in 
humans predicted individual variation in brain serotonin synthesis in frontal limbic regions 
vivo, using Positron Emission Tomography (Booij et al., 2012), supporting the relevance of 
this gene for controlling brain 5-HT synthesis in humans in brain regions involved in emotion 
regulation.
The TPH1 gene has two common polymorphisms in intron 7 consisting of an A to C 
substitution at nucleotides 779 (A779C) and at 218 (A218C) which are in tight, but not 
complete, linkage disequilibrium. Literature on the association between variation in the 
TPH1 gene and depression or aggression/suicidality is inconsistent (Lalovic and Turecki, 
2002, Bellivier et al., 2004).
Since TPH2 is expressed only in the brain, the TPH2 gene (located on chromosome 12q15) 
is arguably a more promising candidate gene to investigate the association between TPH and 
suicidality, aggression and depression (Bondy et al., 2006). Variations in TPH2 polymorphisms 
have previously been associated with MDD, suicide, anxiety and hyperactivity (Booij et al., 
2012). Moreover, TPH2 haplotype linkage to anxiety/depression phenotypes and suicide 
attempts bas been identified in 2 different populations (Zhou et al., 2005, Zill et al., 2004). 
However, many inconsistencies in the literature still occur.
MAOA gene
The MAOA gene was associated with aggression in the early 2000s in the Dunedin study 
(Silva and Stanton, 1996, Arseneault et al., 2000, Caspi et al., 2003) and has since been 
identified as the ‘warrior gene’ in popular media. The monoamine oxidase A (MAOA) gene 
has been studied mainly in association with aggression. MAOA is an enzyme essential for the 
degradation of monoamines in the central nervous system (Oreland, 1991). The MAOA gene 
is located on the X chromosome (Xp11.23-11.4) and one of the most investigated variations 
is that of a variable number of tandem repeats (VNTR). Alleles with 3.5 or 4 copies lead to 
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2-10 times more efficient transcriptional activity (indicating high expression; MAOA-H) than 
alleles with 3 copies (low expression; MAOA-L) (Sabol et al., 1998).
The MAOA enzyme has both been linked to aggression and to the development and 
pharmacological treatment of depression (Aklillu et al., 2009, Pare, 1985). Recently, variations 
in other polymorphisms than the VNTR were also found to be related to levels of anger 
expressed outwards by male and female suicidal patients (Antypa et al., 2012) (63.7% of which 
were patients with affective disorder).
Gene by environment interaction
Although the examples given indicate that variants of certain polymorphisms may predispose 
to depression and aggression, the putative vulnerability of carrying a certain variant may 
especially be expressed in the presence of adverse events, e.g. childhood maltreatment or 
stressful life events.
For example, the association between stressful life events and depression was stronger 
in carriers of at least one s allele of the 5-HTTLPR compared to ll homozygotes (Caspi et 
al., 2003). Null findings have also been reported, although a meta-analysis confirmed this 
association (Karg et al., 2011), and some of the non-significant studies appear to be attributed 
to less rigorous methodology.
Childhood maltreatment can result in symptoms of depression as well as antisocial behavior 
later in life; however, MAOA-H carriers seem less likely to develop antisocial behavior after 
childhood maltreatment than MAOA-L carriers (Caspi et al., 2002). Little is known about 
gene by environment interactions of other commonly studied 5-HT genes associated with 
depression.
Research aims & outline of this thesis
This thesis investigates the significance of anger regulation problems in the context of 
depression. Both depression and aggression have been studied extensively, but although 30-
40% of depressed patients may have aggression problems, reports on the significance and 
implications of their co-occurrence are limited. Aggression as well as depression have been 
associated with some similar biological mechanisms (5-HT, genetic, neuroendocrine, and 
psychophysiological). This thesis may shed some light on the extent to which the presence 
of anger regulation problems represents a putative subtype of depression, possibly guiding 
treatment preferences as well.
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In Chapter 2, we compare currently depressed patients reporting irritability to those not 
reporting irritability in terms of clinical and demographic characteristics. For this comparison, 
we use data from the Netherlands Study of Depression and Anxiety (NESDA), from which we 
selected the 913 participants who met the criteria for major depression, minor depression, or 
dysthymia during the month prior to study admission. We compare those with and without 
irritability on clinical features, psychological characteristics and physiological measures.
Heritability appears to contribute to the development of psychopathology, and heritability 
of both depression and aggression has been studied extensively. However, little is known on 
the heritability of aggression regulation problems in the context of depression. The aim of 
Chapter 3 is to investigate a possible genetic mechanism for the occurrence of aggression in 
the context of depression. To investigate this, we specifically focus on the association between 
monoamine oxidase A (MAOA) genotypic variation and aggression, especially in well-
documented interaction with childhood trauma (Caspi et al., 2002, Kim-Cohen et al., 2006, 
Haberstick et al., 2005). To investigate the role of the MAOA gene in aggression in the context 
of depression, we test whether the low expression variant is associated with trait and state 
measures of anger and measures of aggression including cognitive reactivity to sad mood.
Since both depression and aggression have repeatedly been associated with lower 5-HT 
neurotransmission, our next step is to investigate 5-HTergic vulnerability in aggression in the 
context of depression. Specifically, given the association with lower 5-HT neurotransmission, 
we investigat whether patients with depression and aggression problems have more 
impairment in the 5-HT system compared to patients without aggression during depression 
using ATD. Chapters 4 and 5 discusses the results of this experimental study we conducted, 
where remitted depressed patients with (MDD+A) and without (MDD-A) anger problems 
during their depression participated in an acute tryptophan depletion (ATD) study. In 
Chapter 4, we examine differences in depressive symptom reactivity in response to ATD 
between remitted depressed patients with (MDD+A) and without (MDD-A) anger regulation 
problems during their depression. We also investigate testosterone and cortisol responses, two 
hormones implicated in both in depression as well as aggression. In Chapter 5, we investigate 
differences in cognition between the MDD+A and MDD-A group; more specifically, we 
investigate whether depression with anger regulation problems is associated with increased 
impulsivity compared to depression without anger regulation problems. Moreover, we 
investigate differences in recognition of and reaction to emotional faces.
A summary of chapters 2-5 and a General Discussion of the studies in this thesis are given in 
Chapter 6.
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Chapter 2 
Clinical and physiological correlates of irritability 
in depression: results from the Netherlands study 
of depression and anxiety
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Abstract
Objective: Irritable and non-irritable depressed patients differ on demographic and clinical 
characteristics. We investigated whether this extends to psychological and physiological 
measures.
Method: We compared irritable and non-irritable unipolar depressed patients on 
symptomatology, personality, and (psycho)physiological measures (cortisol, cholesterol, and 
heart rate variability). Symptomatology was reassessed after one year, and we also compared 
depressed patients who were irritable or non-irritable at both time points (Irr++ versus Irr−−).
Results: Almost half (46%; N = 420) of the sample was classified as irritable. These patients 
scored higher on depression severity, anxiety, hypomanic symptoms, and psychological 
variables. No differences were observed on physiological markers after correction for 
depression severity. The same pattern was found when comparing Irr++ and Irr−− groups.
Conclusion: Irritable and non-irritable depressed patients differ on clinical and psychological 
variables, but not on the currently investigated physiological markers. The clinical relevance of 
the distinction and the significance of the hypomanic symptoms remain to be demonstrated.
Thesis.indd   34 05-10-14   23:36
35
Introduction
Not all symptoms that are prevalent in major depression are part of its diagnostic criteria 
(American Psychiatric Association, 2001). For instance, most depressed patients experience 
significant levels of anxiety. Irritability is also reported by many. In children, irritability is 
the most common symptom of depression (Crowe et al., 2006) and is one of the diagnostic 
criteria. Two recent studies have examined the clinical significance of irritability in depression 
in adults. In a community sample of depressed patients, approximately half of the 955 patients 
with lifetime unipolar depression were also irritable during their worst episode (Fava et al., 
2009), as measured with one item of the Composite International Diagnostic Interview. 
Depressed patients scoring positive on irritability had a younger age of onset and higher 
rates of comorbid attention-deficit/hyperactivity disorder, oppositional-defiant disorder, 
intermittent explosive disorder, dysthymia and anxiety disorders (Fava et al., 2009). A second 
study (Perlis et al., 2009) compared depressed patients with and without irritability based on 
the irritability item of a standardized symptom interview. Irritable depressed patients (N = 1, 
067; 46%) reported more anxiety, loneliness and annoyance by daily hassles, and more prior 
suicide attempts than non-irritable depressed patients. Previous research by the same group 
focused on a depression subtype characterized by the presence of anger attacks, in other words 
by disturbances in the regulation of irritability (Fava et al., 1990, Fava and Rosenbaum, 1998, 
1999). Around 40% of depressed outpatients had one or more anger attacks during the past 
month (Fava et al., 1997, Fava et al., 1993). In comparison with depressed patients without 
anger attacks, these patients had higher levels of hostility, anxiety, somatization (Fava et al., 
1993), higher cholesterol levels (Fraguas et al., 2007), more axis II psychopathology (Tedlow 
et al., 1999), increased risk of cardiac dysfunction (Iosifescu et al., 2007), and a younger age 
of depression onset (Alpert et al., 2003). Depressed patients with anger attacks also showed a 
blunted response to the serotonin (5-HT) agonist fenfluramine (Fava et al., 2000). Compared 
to healthy controls, depressed patients with anger attacks showed differential activation of 
orbitofrontal–limbic circuits following an anger induction task (Dougherty et al., 2004). It 
has been suggested that irritability may also be a feature of unrecognized bipolar (spectrum) 
disorder (Benazzi, 2003, 2010, Benazzi and Akiskal, 2005). It has not been investigated yet 
to what extent irritability during a depressive episode predicts the development of bipolar 
disorder. However, other features of bipolar disorder, such as early age of onset, suicidality, 
family history, greater episode recurrence, and atypical depression were not found to be more 
common in the irritable depressed (Perlis et al., 2009). The present study had two aims. The 
first aim was to investigate whether the psychological and biological profile that has been 
found for depressed patients with anger attacks also applies to depressed patients with 
irritability. We compared outpatients with irritable and non-irritable unipolar depression 
on demographic, clinical, psychological, and biological markers that had previously been 
associated with impulsivity, aggression, or anger attacks. These markers include personality, 
cognitive reactivity, heart rate variability (Iosifescu et al., 2007), cholesterol (Fraguas et al., 
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2007), and cortisol (Van Praag, 1996a). We hypothesized that depressed patients reporting 
irritability would score higher on anxiety and suicidality, lower on agreeableness, and higher 
on aggression reactivity. We also expected that irritable depression would be associated with 
lower heart rate variability, lower cholesterol concentrations, and higher levels of cortisol, 
particularly the cortisol awakening rise. The second aim was to investigate the association of 
irritability in depression with features of (hypo-)mania. For this, we measured (hypo-)manic 
symptoms in the same patients.
Methods
Participants 
Participants were selected from the Netherlands Study of Depression and Anxiety (NESDA). 
This cohort study follows 2,981 adult participants over the course of 8 years (Penninx et al., 
2008). NESDA respondents were recruited from the community and through primary and 
secondary care facilities. The total NESDA sample contains 2,329 individuals with a lifetime 
diagnosis of depression, dysthymia and/or an anxiety disorder, and 652 healthy participants. 
Participants with a diagnosis of bipolar disorder, a psychotic disorder, obsessive compulsive 
disorder, or severe addiction disorder are excluded from NESDA. For the present study, we 
selected the 913 participants who met the criteria for major depression, minor depression, or 
dysthymia during the month prior to study admission.
Instruments
Diagnoses 
Current and past DSM-IV diagnoses of mood disorders, anxiety disorders, and alcohol abuse 
and dependency were assessed with the Composite International Diagnostic Interview (CIDI) 
(Robins et al., 1988). The interviews were conducted and scored by trained and supervised 
clinical research staff. Psychotic disorders and addictions were assessed in an open interview 
and checked in the medical records. Severity of alcohol dependence and abuse was assessed 
with the Audit questionnaire (Babor et al., 1989).
Symptomatology 
Severity of depression during the past week was defined as the total score on the Inventory 
of Depressive Symptomatology (IDS-SR) (Rush et al., 1996), excluding the irritability item. 
Anxiety symptoms were assessed with the Beck Anxiety Index (BAI) (Beck et al., 1988). 
The BAI measures the somatic and cognitive aspects of anxiety during the past week (e.g., 
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“numbness or tingling” and “fear of the worst happening”). It contains 21 items, scored on 
a four-point scale. The symptoms of bipolar disorder were assessed with the Mood Disorder 
Questionnaire (MDQ) (Hirschfeld et al., 2003), which contains 13 items derived from DSM-
IV criteria and clinical experience (e.g., “you were so irritable that you shouted at people or 
started fights or arguments” and “you felt more self-confident than usual”).
Irritability
Irritability status was determined using one item from the Inventory of Depressive 
Symptomatology— Self-Report (IDS-SR) (Rush et al., 1996). This item asks whether the 
participant has been “feeling irritable during the past seven days”. The answers are scored on a 
four-point scale with descriptors “not feeling irritable” (1), “feeling irritable less than half the 
time” (2), “feeling irritable more than half the time” (3), or “feeling extremely irritable nearly 
all of the time” (4). The sample was split into low (scoring 1 or 2) (Irr−) and high irritable 
groups (scoring 3 or 4) (Irr+). The validity of this criterion has been shown previously in 
other cohorts (Fava et al., 2009, Perlis et al., 2009), but since the IDS measures past week 
severity only, irritability was reassessed at a one-year follow-up. This allowed us to create 
somewhat more extreme subgroups of depressed patients who were irritable both at baseline 
and at one-year follow-up (Irr++) and patients who were non-irritable on both assessments 
(Irr−−).
Suicidality
Previous suicide attempts were assessed with the Beck scale for suicide ideation (Beck and 
Beamesderfer, 1974).
Psychological Variables
Cognitive vulnerability to depression was measured with the Leiden Index of Depression 
Sensitivity—Revised (LEIDS-R) (Van Der Does, 2002, Williams et al., 2008). The LEIDS-R, 
a 34- item self-report scale, measures cognitive reactivity to sad mood on the following 
subscales: hopelessness/suicidality, acceptance/coping, aggression, control/perfectionism, 
risk aversion and rumination. Personality traits were assessed with the short form of the NEO 
Five Factor Inventory (NEOFFI) (Costa and Mccrae, 1995).





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cortisol awakening response was used to investigate HPA-axis function (Wüst et al., 2000). 
During the baseline assessment, patients were instructed to collect four cortisol samples on 
a regular (working) day shortly after the interview. Samples were taken at awakening and 
at 30, 45, and 60 minutes after the first sample, after which they were returned by mail after 
collection. Median time between the interview and saliva sampling was 9.0 days (25th–27th 
percentile, 4–22 days). Outcome measures were the area under the curve with respect to the 
ground (AUCg) and the area under the curve with respect to the increase (AUCi) (Pruessner 
et al., 2003, Vreeburg et al., 2009a).
Cholesterol 
Total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL), and 
cholesterol levels (both measures of serum cholesterol) were assayed from a blood sample 
taken after an overnight fast (Van Reedt Dortland et al., 2010).
Heart Rate Variability (HRV)
Heart rate variability (HRV) was assessed using a VU-AMS monitoring system (De Geus et 
al., 1995) which was worn during most of the baseline measurement (average registration 
99.9 minutes). The various phases of the session (resting baseline, interviews, and a cognitive 
task) were marked using an event button. Mean heart rate, standard deviation of the interbeat 
intervals (SDNN), and the different measures of respiratory sinus arrhythmia (RSA) were 
calculated from the interbeat interval (IBI) time series and respiration signal (De Geus et 
al., 1995, Goedhart et al., 2007, Houtveen et al., 2002). For the current study, we investigated 
SDNN and RSA measured in (supine) rest condition (during which no interview was 
conducted) and during performance of a cognitive test (test condition) (Licht et al., 2008).
Data Screening
Data were checked for missings and outliers, normality of distributions, and homogeneity of 
variances. 145 of the 913 participants did not return their questionnaire package resulting in 
145 missings on all variables of the LEIDS-R. On the age of onset variable, 162 participants 
had missing values. In about half of the other variables, a low number of missing values (<20) 
were replaced with the series mean of their subgroup (Irr+/Irr−) according to Tabachnik 
and Fidell (Tabachnik and Fidell, 2007). The dataset was complete for the other variables. 
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Table 2







Age of Onset (mean±SD) 29.0 ± 13.2 26.9 ± 12.4 .001
Beck Anxiety Inventory (mean±SD) 16.6 ± 9.5 23.9 ± 11.3 .008 **
LEIDS (mean±SD)
















* .085 < p > .05
** .05 < p > .001
***p < .001
a Controlled for current symptoms (IDS-total minus item 6), gender and age.
































(n = 470)  (n = 404)

















a Controlled for sex, physical activity, cardiovascular disease, time of awakening and hours 
of sleep.
b Controlled for smoking, physical activity, cardiovascular disease, working on testing day, 
hours of daylight in month of testing.
c Controlled for current symptoms (IDS-total minus item 6), sex, age, smoking, alcohol 
abuse and dependence and antidepressant use.
d Controlled for current symptoms (IDS-total minus item 6), sex, age, smoking, alcohol 
abuse and dependence, antidepressant and heartmedication-use and heart disease.
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After removal of outliers (scores higher or lower than 2 standard deviations from the mean) 
(Vreeburg et al., 2009a), cortisol data were normally distributed. There were no statistical 
outliers (based on Cook’s distances and studentized residuals) on any of the other variables.
Statistical Analyses
Group differences (Irr+ versus Irr−) were investigated by general linear models (GLMs). This 
was done in two steps. First, data were explored by using separate univariate GLMs with group 
(Irr+/Irr−) as the between subjects factor. Alpha was set at 0.05, however all outcome variables 
significant at the P < .15 level in these univariate analyses were entered in a multivariate GLM 
to take into account correlations among the dependent variables. Covariates were included in 
the univariate and multivariate analyses in order to reduce error variance (Stevens, 2002). The 
choice of covariates in each of the analyses was based on literature review and results of previous 
studies conducted in NESDA (Penninx et al., 2008, Vreeburg et al., 2009b). Age, gender, and 
current depression symptoms were included as covariates in the GLMs for the LEIDS-R and 
NEO-FFI subscale and total scores. For the cortisol measures, we entered physical activity, 
smoking, cardiovascular disease, whether the participant was working on the day of data 
collection and hours of daylight in the month of data collection as covariates. In the HRV and 
cholesterol analyses, covariates were age, gender, depression severity, alcohol dependence and 
abuse, use of antidepressants, and heart medication. Participants were classified as nonsmoker, 
former smoker, smoker, or heavy smoker (>20 tobacco consumptions a day), and similar 
categories were made for alcohol use: nondrinker, mild drinker (<7 units/week), moderate 
drinker (7–14 u/wk), and heavy drinker (≥15 u/wk). Energy spent on physical activity per 
week was measured with the International Physical Activity Questionnaire (Booth, 2000). 
Chi-square statistics were used in case of categorical variables. Logistic regression analysis 
was used to control for potential confounders in relationships involving categorical variables.
Results
Demographic and Clinical Characteristics
Univariate analyses showed that the irritable depressed group was significantly older than 
the non-irritable depressed group (F(1, 911) = 10.7; P = .001). There was no significant 
difference in the distribution of males and females over the two groups (χ²(1) = .004; P = .95). 
Participants in the Irr+ group had been recruited from specialized mental health institutions 
more often than participants in the Irr− group (χ²(2) = 16.4; P < .001). Table 1. shows that the 
Irr+ group also had notably higher scores on severity of depression (IDS total minus Item 6; 
Irritability) (F(1, 911) = 232.9; P < .001) than the Irr− group. This pattern was present at each 
recruitment site, with 9 points difference between Irr+ and Irr− in primary care (F (1, 367) = 
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76.6; P < .001) and specialized mental health care (F(1, 466) = 102.3; P < .001) and 13 points 
difference in the general population (F (1, 72) = 47.5; P < .001). Irr+ participants also had 
higher anxiety (BAI total) symptoms (F(1, 911) = 134.2; P < .001) and more lifetime anxiety 
disorders (χ²(1) = 5.5; P = .019). Current GAD (χ²(1) = 14.7; P < .001), panic disorder (χ²(1) 
= 22.8; P < .001), and social anxiety disorder (χ²(1) = 17.3; P < .001) were also more prevalent 
in the Irr+ group. More patients in the Irr+ group had previously attempted suicide than 
patients in the Irr− group (25% versus 17%; χ²(1) = 8.3; P = .004). However, an additional 
logistic regression analysis showed that the association between irritability and suicidality was 
no longer statistically significant after controlling for depression severity. Patients in the Irr+ 
group scored higher on three mania items of the MDQ: talkativeness (χ²(1) = 4.03; P = .045), 
racing thoughts (χ²(1) = 10.47; P = .001), and distractibility (χ²(1) = 14.57; P < .001).
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Cognitive Vulnerability
The Irr+ group scored higher on all subscales of the LEIDS-R, with exception of the acceptance 
subscale. The Irr+ group also had a significantly higher LEIDS-R total score (F(1, 766) = 68.8; 
P < .001). After adding age, gender, and IDS total score as covariates, only the difference 
between the scores on the aggression subscale of the LEIDS-R remained significant (F(1, 763) 
= 39.4; P < .001).
Personality
The Irr+ group had significantly higher neuroticism scores (F(1, 908) = 116.06;P < .001) and 
scored significantly lower on extraversion (F(1, 908) = 39.48; P < .001), openness (F(1, 909) = 
6.71; P = .010), agreeableness (F(1, 908) = 48.58; P < .001), and conscientiousness (F(1, 908) 
= 5.38; P = .021) than the Irr- group. After correcting for age, gender, and total IDS score, the 
differences on neuroticism and agreeableness remained statistically significant.
Multivariate Analyses
The multivariate analyses (shown in Table 2.) yielded similar results, with significant 
differences between Irr+ and Irr− on BAI total score (F(1, 619) = 4.84; P = .028), LEIDS-R 
aggression (F(1, 619) = 48.40; P < .001), and agreeableness (F(1, 619) = 14.96; P < .001). 
Neuroticism was significant at trend level (F(1, 619) = 3.71; P = .055)
Physiological Variables
Table 3. shows the outcomes on the (psycho)physiological markers. There were no significant 
differences in cortisol awakening response (CAR) between the Irr− and Irr+ irritable group. 
HDL cholesterol was significantly higher in the Irr− group (F(1, 911) = 5.69; P = .017), but 
this difference was no longer significant after entering the covariates gender, age, smoking, 
alcohol abuse and dependence, and antidepressant and heart-medication use. Both groups 
did not differ significantly on measures of HRV either (all P values > .12), with and without 
correction.
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Irritability at One-Year Follow-up
Depressed patients who were irritable both at baseline and at one-year follow-up (Irr++) (N 
= 138) differed from depressed patients who were non-irritable on both baseline and one-
year follow-up (Irr−−) (N = 202) on largely the same outcomes. Fewer patients in the Irr++ 
group were recruited from primary health care or the community (χ²(1) = 5.67; P = .020), 
and they scored higher on comorbid anxiety disorders. Their depression severity (IDS minus 
irritability) was also higher (F(1, 338) = 77.74; P < .001). They scored higher on aggression 
reactivity (F(1, 319) = 36.35; P < .001) and total LEIDS-R score (F(1, 319) = 3.94; P = .048), 
after correction for depression severity, age, and gender. Irr++ participants also had higher 
neuroticism (F(1, 335) = 12.94; P < .001) and lower agreeableness (F(1, 335) = 8.62; P = .004) 
scores, after correction for age, gender, and depression severity. No physiological differences 
were found between the Irr++ and Irr−− groups.
Discussion
The present study showed that approximately half of the patients with a primary diagnosis 
of unipolar depression also have high levels of irritability. This is consistent with earlier 
research (Fava et al., 2009, Perlis et al., 2009). Other studies have shown that the prevalence 
of anger attacks in patients with unipolar depression is only slightly lower at approximately 
40% (Fava and Rosenbaum, 1998, Fava et al., 1991, Fava et al., 1993). These studies, however, 
concerned patients recruited from secondary care facilities. In the current study, almost 60% 
of the patients recruited from psychiatric outpatient departments were classified as irritable. 
Irritability has been defined as “a feeling characterized by reduced control of temper” which 
often results in verbal or behavioral aggression (Snaith and Taylor, 1985). Although irritability 
should be distinguished from more violent forms of aggressive and assaultive behavior, milder 
and more severe forms of irritability (e.g., anger attacks) may lie on a continuum (Snaith 
and Taylor, 1985). Future research may investigate the exact relationship between irritability 
during depression and its outward manifestations such as anger attacks.
Clinical Characteristics of Irritable versus non-Irritable Depression
Irritable depressed patients were more severely depressed than non-irritable depressed 
patients. The difference in IDS scores was 10 points, which is more than one standard 
deviation. The severity of anxiety symptoms and suicidality was also higher. Moreover, 
irritable depressed patients were more often diagnosed with a comorbid anxiety disorder. 
The onset of depression was approximately two years earlier in the irritable depressed. They 
were also somewhat older at study entry and were more often recruited from secondary care 
facilities. With regards to their psychological profile, differences between irritable and non-
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irritable depressed patients were observed on a broad range of personality traits and cognitive 
vulnerability indices. However, after correction for depression severity, irritable depressed 
patients only had higher scores of aggression reactivity and lower scores of the personality 
trait agreeableness. Although participants are categorized into high- and low-irritable groups 
on the basis of one symptom, the psychological profile observed in the present study supports 
the validity of the subgroups.
Physiological Differences between Irritable and non-Irritable Depression
We found no differences between irritable and non-irritable depressed patients on any of 
the physiological markers that were investigated. Although HDL cholesterol was significantly 
higher in non-irritable patients, this result was no longer significant after correction for 
several covariates. No differences were observed on measures of heart rate variability 
(HRV) and cortisol awakening rise (CAR). We subsequently investigated the possibility that 
these physiological markers are related to more stringently defined subtypes, by selecting 
participants who were also depressed at one-year follow-up and showed either high or low 
scores of irritability at both time points. This comparison produced exactly the same pattern 
of findings. Irritable depressed patients had a greater prevalence of anxiety disorders and 
higher depression severity and aggression reactivity. Again, no differences were found on any 
of the physiological measures after correction for overall depression severity. The absence of 
differences at the physiological level was unexpected since studies in healthy samples have 
found greater HPA-axis reactivity (Bohnke et al., 2010, Gerra et al., 1997) and increased 
cardiac reactivity as a function of hostility and aggression (Neumann et al., 2004, Virtanen et 
al., 2003). However, in a population-based sample anxiety and hostility were not related with 
HRV but with baroreflex sensitivity, which may be a more sensitive measure of vagal activity 
(Virtanen et al., 2003). In depressed patients, the studies that investigated cardiac and HPA-
axis reactivity concern comparisons between patients with and without anger attacks. These 
studies found higher cholesterol concentrations in depressed patients with anger attacks (Fava 
et al., 1996). We found no support for this finding in the present sample of irritable versus 
non-irritable depressed patients.
In the present study, HRV was assessed at rest and during a task that required cognitive effort. 
Cortisol samples were collected at home. It has been suggested that depressed patients with 
anxiety-aggression behaviors also have a greater sensitivity to stress (Van Praag, 1996b). It 
could be that irritable depressed patients only show greater HPA-axis and cardiac reactivity 
when exposed to a more significant stressor than performing a cognitive test. This could be 
further tested using the same measures as in the present study in combination with laboratory 
stress or anger induction paradigms. The clinical and psychological characteristics observed in 
the irritable depressed patients resemble a subtype of depression proposed by Van Praag (Van 
Praag, 1994, 1996b, 2001). He stated that aggression combined with anxiety is the primary 
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feature of a subtype of depression which he called “stressorprecipitated, cortisol-induced, 
serotonin-related, anxiety/aggression- driven” (SeCA) depression (Van Praag, 1996a). This 
subtype may be further characterized by increased 5-HT disturbances, in which low mood 
is a secondary symptom (Van Praag, 1994) and with aggression disturbances as primary 
symptom. Unfortunately, markers of 5-HT function were not available in the present study.
Symptoms of Bipolar Disorder in Irritable versus non-Irritable 
Depression
We also observed differences between irritable and non-irritable depressed patients on three 
symptoms of hypomania as measured by the MDQ: distractibility, talkativeness, and racing 
thoughts. Future longitudinal analyses of NESDA participants may show whether irritability 
during depression is a risk factor for the development of bipolar disorder.
Strengths and Limitations of the Current Study
The current study had several strengths, including a rather large sample size of currently 
depressed patients. Diagnoses were determined using a standardized interview. Patients were 
recruited from different sites and facilities, which increases the generalizability of the findings. 
The cross-sectional design is a limitation. This was partially remediated by the inclusion of a 
one-year follow-up measurement of the clinical variables, which allowed us to investigate a 
more stable subgroup of irritable depressed patients. Although other studies used the same 
method (Fava et al., 2009, Perlis et al., 2009), the fact that the distinction between irritable 
and non-irritable depressed was based on just one symptom can be seen as a limitation. We 
interpret the selective differences on cognitive reactivity and personality as supporting the 
validity of the distinction.
Future Directions
Our findings indicate several clinical differences between depressed patients with and without 
irritability. High levels of irritability during depression are associated with more severe 
depression, higher levels of anxiety, and more comorbid anxiety disorders. Anxiety during 
depression is associated with poorer outcome, including higher risk of chronic depression, 
poorer treatment response (Van Valkenburg et al., 1984), and increased suicide incidence 
(Fawcett and Kravitz, 1983). Moreover, we found higher levels of aggression reactivity, 
hopelessness, and disagreeableness in irritable depressed patients. Both hopelessness and 
aggression reactivity have been associated with increased suicide risk (Antypa et al., 2009). 
Therefore, it is important to continue the investigation into possible underlying mechanisms 
of this form of depression. There is evidence that depressed patients with aggression 
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dysregulation problems have more pronounced 5-HT alterations (Cleare and Bond, 2000, 
Lopez-Ibor et al., 1985, Van Praag, 1994, 1996b, Young et al., 2007). Moreover, there is some 
evidence that depression in combination with aggression (hostility, anger) is partly under 
genetic control (Gonda et al., 2011).
Conclusion
In this cross-sectional assessment, approximately half of depressed patients were classified as 
irritable. These patients differ from low-irritable depressed patients on several other aspects of 
the clinical presentation, including depression severity and comorbid anxiety. Personality and 
cognitive vulnerability measures also differ between these groups. Future longitudinal studies 
in depressed patients are needed to investigate the consequences of high levels of irritability 
in terms of risk of bipolar disorder, course of disease and treatment response.
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Chapter 3 
The effects of MAOA genotype, childhood trauma, 
and sex on trait and state-dependent aggression
Floor E. A. Verhoeven, Linda Booij, Anne-Wil Kruijt, Hilâl Cerit, Niki Antypa & 
Willem Van der Does
Adapted from Verhoeven, F. E., Booij, L., Kruijt, A. W., Cerit, H., Antypa, N., & Does, 
W. (2012). The effects of MAOA genotype, childhood trauma, and sex on 
trait and state‐dependent aggression. Brain and behavior, 2(6), 806-813. 
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Abstract
Monoamine oxidase A (MAOA) genotypic variation has been associated with variation in 
aggression, especially in interaction with childhood trauma or other early adverse events. 
Male carriers of the low-expressing variant (MAOA-L) with childhood trauma or other early 
adverse events seem to be more aggressive, whereas female carriers with the high-expressing 
variant (MAOA-H) with childhood trauma or other early adverse events may be more 
aggressive. We further investigated the effects of MAOA genotype and its interaction with sex 
and childhood trauma or other early adverse events on aggression in a young adult sample. 
We hypothesized that the association between genotype, childhood trauma, and aggression 
would be different for men and women. We also explored whether this association is different 
for dispositional (trait) aggression versus aggression in the context of dysphoric mood. In all, 
432 Western European students (332 women, 100 men; mean age 20.2) were genotyped for 
the MAOA gene. They completed measures of childhood trauma, state and trait measures 
of aggression-related behaviors (STAXI), and cognitive reactivity to sad mood (LEIDS-R), 
including aggression reactivity. Women with the MAOA-H had higher aggression reactivity 
scores than women with the MAOA-L. This effect was not observed in men, although the 
nonsignificant findings in men may be a result of low power. Effects on the STAXI were 
not observed, nor were there gene by environment interactions on any of the aggression 
measures. A protective effect of the low-expression variant in women on aggression reactivity 
is consistent with previous observations in adolescent girls. In females, the MAOA-H may 
predispose to aggression-related problems during sad mood.
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Introduction
Monoamine oxidase A (MAOA) is an enzyme essential for the degradation of monoamines in 
the central nervous system (Oreland, 1991). Previous research has shown that MAOA plays 
a major role in aggression. In one of the first studies, a point-mutation in the gene that codes 
for MAOA, causing complete MAOA deficiency, was associated with criminal and violent 
behaviors in males. This effect was seen over multiple generations in the family studied 
(Brunner et al., 1993). This link between lower MAOA enzyme activity and aggression has 
been confirmed in studies using animal models (Cases et al., 1995) and in human studies 
that used positron emission tomography to measure MAOA function in vivo (Alia-Klein et 
al., 2008, Soliman et al., 2011). The MAOA gene is located on the X chromosome (Xp11.23-
11.4) and has a variable number of tandem repeats (VNTR). Alleles with 3.5 or 4 copies lead 
to 2–10 times more efficient transcriptional activity (indicating high expression; MAOA-H) 
than alleles with three copies (low expression; MAOA-L) (Sabo et al., 1998). An early study 
showed that maltreated boys with the MAOA-L genotype were at greater risk to develop 
antisocial problems than maltreated boys with the MAOA-H genotype (Caspi et al., 2002). 
This finding has been replicated (Cicchetti et al., 2010, Ducci et al., 2008, Enoch et al., 2010, 
Foley et al., 2004, Huang et al., 2004, Kim-Cohen et al., 2006, Nilsson et al., 2006) but not 
consistently (Alia-Klein et al., 2008, Young et al., 2006). Although most studies have shown 
that the MAOA-H variant is associated with less aggressive behavior in males, this variant may 
be a risk factor for increased aggressive behaviors in adolescent girls who experience early 
psychosocial risk factors (Åslund et al., 2011, Sjoberg et al., 2007). Problems in aggression 
regulation are a common symptom of many psychiatric disorders. For instance, up to 30–
40% of depressed patients seem to experience some form of aggression regulation problems 
during their depression, ranging from irritability (Perlis et al., 2009, Verhoeven et al., 2011) 
to anger attacks (Fava and Rosenbaum 1999, Van Praag, 2001). Consistent with this, MAOA 
has been linked to both aggression and the development and pharmacological treatment of 
depression (Aklillu et al., 2009, Pare, 1985). This may suggest that the relationship between 
MAOA and aggression depends on the context of aggression. Indeed, a previous study has 
shown that the effects of the MAOA gene on aggression are most prominent in an aggression-
provoking situation (Mcdermott et al., 2009). It is therefore of interest to assess the role of 
the MAOA gene in aggression-related behaviors in the context of sad mood. In this study, we 
investigated the effects of MAOA genotype and its interaction with sex and early adversity 
on different aspects of aggression in young adults, that is, state aggression but also aggression 
in the context of depression. We hypothesized that the association between genotype and 
childhood trauma would be different for men and women. Specifically, we expected that 
male carriers of the low-expression MAOA variant would express higher levels of aggression-
related behaviors than carriers of the high-expression variant, in particular in the context of 
early adversity. We expected an opposite pattern in females.




A total of 432 participants aged between 17 and 39 participated in the study (332 women, 
100 men). Participants were recruited via advertisements, flyers, and posters in the university 
buildings (University of Leiden, the Netherlands). Participants had to be of Western European 
descent (i.e., all four grandparents born in the Netherlands, Germany, France, Belgium, 
Luxemburg, Austria, Switzerland, Ireland, the United Kingdom, or Scandinavia). Those 
suffering from a current depressive episode were excluded from the analyses. The presence of 
more women than men in the current sample is useful because, unlike men, women can be 
either hetero- or homozygous for the MAOA genotype.
Measures 
Childhood trauma was measured using the 28-item version Childhood Trauma Questionnaire 
(CTQ) (Bernstein et al., 1997, Thombs et al., 2009). This self-report questionnaire has been 
validated both in clinical and in nonclinical samples. The CTQ has five subscales (Emotional 
abuse, Physical abuse, Sexual abuse, Emotional neglect, and Physical neglect) and each item is 
rated on a Likert scale ranging from 1 (never true) to 5 (very often true). We divided participants 
in two groups: those who reported none/minimal-to-moderate levels of childhood trauma 
and those who reported moderate-to-severe levels of childhood trauma. The distinction was 
based on severity norm scores from a sample of North American college students (Bernstein, 
D. P. et al., 1997), with participants scoring lower than the cutoff score of 38 assigned to 
the none/ minimal-to-moderate levels of childhood trauma group and those scoring over 
38 assigned to the moderate-to severe levels of childhood trauma group. The Spielberger 
State-Trait Anger Expression Inventory (STAXI) (Forgays et al., 1997, Spielberger et al., 1983, 
Van Der Ploeg et al., 1982) was used to measure aggression- related behaviors both as an 
emotional state and as a personality trait. Both versions of the STAXI consist of 10 items with 
a 4-point Likert scale. Cognitive reactivity was measured with the Leiden Index of Depression 
Sensitivity – Revised (LEIDS-R) (Van Der Does, 2002, 2005, Williams, 2008). This 34- item 
self-report questionnaire has six subscales (Aggression Reactivity [AGG], Hopelessness/
Suicidality Reactivity [HOP], Acceptance/Coping [ACC], Control/Perfectionism [CTL], Risk 
Aversion [RAV], and Rumination on Sadness [RUM]). It instructs participants to indicate 
how their thinking patterns change when they experience mild dysphoria. Questions are 
answered on a 0–4 Likert scale. The AGG and HOP subscales and the LEIDS-R total score 
were the primary outcome measures for this study. The AGG and HOP reactivity subscales 
have been found to be strongly associated with irritability in depressed patients (Verhoeven 
et al., 2011) and with suicidality (Antypa and Van Der Does, 2010, Verhoeven et al., 2011). 
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The LEIDS-R total score is associated with serotonin vulnerability (response to tryptophan 
depletion) (Booij and Van Der Does, 2007) and with the interaction of serotonin transporter 
gene polymorphism and early-life events (Antypa and Van Der Does, 2010). 
Procedure
All measures were obtained in a single session. All participants signed informed consent prior 
to participation and either received €10 or study credits. The research was approved by the 
Ethics Committee of the Institute of Psychology of Leiden University. Saliva samples were 
collected using Oragene Self- Collection Kits – DISC format (DNA Genotek Inc, Ottawa, 
Ontario, Canada); 200 lL of saliva was kept in lysis buffer (100 mmol/L NaCl, 10 mmol/L 
EDTA, 10 mmol/L Tris pH 8, 0.1 mg/mL proteinase K, and 0.5% w/v sodium dodecyl sulfate) 
until further processing. DNA isolation Genomic DNA was isolated from the samples using 
the Chemagic kit on a Chemagen Module I workstation (Chemagen Biopolymer-Technologie 
AG, Baesweiler, Germany). DNA concentrations were quantified by OD260 measurement 
and by agarose gel electrophoresis. The average yield was approximately 4 lg of genomic DNA 
per sample.
Polymerase chain reaction amplification 
The region of interest from the MAOA gene was amplified by triplex polymerase chain 
reaction (PCR) using the following primers: a 6-carboxyfluorescein-labeled Medium 
Resolution (MR) primer (5’-GGATAACAATT TCACACAGG-3’), forward primer 
(5’-ggataacaatttcacacagg ACAGCCTGACCGTGGAGAAG-3’), and a reverse primer 
(5’-GGACCTGGGCAGTTGTGC-3’). Typical PCR reactions contained between 10 and 
100 ng genomic DNA template, 1 pmol of forward primer, and 10 pmol of labeled MR and 
reverse primers. PCR was carried out in the presence of 5% dimethyl sulfoxide with 0.3 U of 
BioThermAB polymerase (GeneCraft, Munster, Germany) in a total volume of 30 lL using the 
following cycling conditions: initial denaturation step of 5 min at 94°C, followed by 38 cycles 
of 30 sec 94°C, 30 sec 55°C, 30 sec 72°C, and a final extension step of 4 min 72°C.
Analysis of PCR products 
One microliter of PCR product was mixed with LIZ-500 size standard and formamide and 
run on an AB 3100 genetic analyzer setup for genotyping with 50-cm capillaries. Results were 
analyzed using Genescan software version 3.7 (Applied Biosystems, Carlsbad, California) and 
alleles were scored visually.
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Statistical analyses 
Following screening for accuracy of data entry and verification of statistical assumptions, chi-
square statistics and generalized linear model (GLM) were used to investigate differences in 
demographic and trauma frequency between the genotypes. Next, the influence of genotype 
and its interactions with childhood trauma and sex were analyzed in two steps. First, we 
included both men and women in the analyses, but excluded the heterozygotes (resulting in N 
= 276). In case of a significant sex by genotype interaction, a second set of analyses in female 
participants only was performed, including both homo- (HH and LL) and heterozygote (HL) 
females. Since MAOA genotype is X-linked, we chose to exclude men in this set of analyses 
to ensure we would only be looking at the effect of genotype without the effect of sex, while 
still obtaining sufficient power. Data were analyzed using GLM for (M)ANOVA, including 
MAOA genotype, childhood trauma, and (when relevant) sex as a between-subject factor. 
In case of threegroup comparisons Tukey’s test was used. IBM SPSS 19 (IBM Corporation, 
Armonk, New York) was used for data analysis.
Results
Preliminary analyses
Genotype frequencies were as follows for men: L, 35%; H, 65%; and for women: LL, 11.10%; 
LH, 47%; HH, 41.90%. As the MAOA-LPR polymorphism is X-linked, the Hardy–Weinberg 
equilibrium can only be reported for women for whom frequencies were in the equilibrium 
(χ²(1) = 0.47; P > 0.05). As data obtained on both STAXI scales were rightskewed, square root 
transformed values were used.
Combined male/female sample (MAOA-H/HH vs. MAOA-L/LL) 
Sample characteristics and mean scores on the behavioral measures, as a function of MAOA 
genotype, are presented in Tables 1. (women) and 2. (men).
Demographics
The group of high-allele carriers (MAOA-H/HH) comprises significantly more women than 
the low-allele (MAOA-L/LL) group (χ²(1) = 10.23; P ≤ 0.01). The groups did not differ in age.







































































































































































No effect of genotype was observed on the STAXI scales. Women scored approximately 2 
points higher than men on the STAXI Trait (F(1, 268) = 5.36; P = 0.02, partial η² = 0.02) and 
1 point on the STAXI State (F(1, 268) = 5.24; P = 0.02, partial η² = 0.02).
Interaction effects




Only on the LEIDS-R HOP scale did we find a main effect. Those who had experienced 
moderate-to-severe levels of childhood trauma scored significantly higher (F(1, 268) = 4.90; 
P = 0.03, partial η² = 0.02) on HOP reactivity. Main effects of MAOA genotype and sex were 
not significant for this scale.
Interaction effects
An interaction effect of MAOA genotype by sex was found for the AGG reactivity scale (F(1, 
268) = 5.48; P = 0.02, partial η² = 0.02) (Figure 1.). The secondary analyses for men and 
women separately revealed that women with the high-expression variant had higher scores 
on this subscale compared with women with the low-expression variant (F(1, 172) = 5.02, P = 
0.03, partial η² = 0.03). No differences were observed in men, nor were there any interactions 
with childhood trauma. For the LEIDS-R total score, we found a significant interaction effect 
between MAOA genotype and sex (F(1, 268) = 7.90; P = 0.01, partial η² = 0.03). A rerun of the 
analysis for men and women separately showed that MAOA-HH women had higher LEIDS-R 
total scores than MAOA-LL women (F(1, 172) = 7.06, P = 0.01, partial η² = 0.04), while no 
differences were observed in men. This post hoc analysis for women separately also revealed 
a significant interaction between genotype and childhood trauma (F(1, 172) = 4.70, P = 0.03, 
partial η² = 0.03). Within the group of women reporting childhood trauma, the HH carriers 
had higher LEIDS-R total scores compared with the LL carriers (F(1, 32) = 8.42, P = 0.01, 
partial η² = 0.21). This effect was absent in women without a history of childhood trauma or 
men.
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Analyses of the secondary outcome measures on the LEIDS-R showed gene by sex interactions 
on both RUM (F(1, 268) = 5.43, P = 0.02, partial η² = 0.02) and RAV (F(1, 27) = 10.03, P ≤ 
0.01, partial η² = 0.04) reactivity. MAOA-HH women scored higher than MAOA-LL women 
on the RUM subscale. A rerun of the analyses for men and women separately showed that 
women with the high-expression variant scored significantly higher than those with the low-
expression variant on RUM (F(1, 172) = 6.43, P = 0.01, partial η² = 0.04) as well as RAV (F(1, 
172) = 4.25, P = 0.04, partial η² = 0.02), whereas in men no such difference was seen. A three-
way interaction effect of MAOA genotype by sex by childhood trauma was detected for the 
RAV subscale (F(1, 268) = 4.67, P = 0.03, partial η² = 0.02). A subsequent analysis for men and 
women with and without childhood trauma history showed that MAOA-HH women with a 
history of childhood trauma had higher risk aversion scores than MAOA-LL women with a 
history of childhood trauma (F(1, 32) = 5.80, P = 0.02, partial η² = 0.15). Such effects were not 
observed for women without childhood trauma, neither were any main or interaction effects 
observed in men only.
MAOA genotype in women
Given the sex by genotype interactions on the LEIDS-R AGG reactivity scale, total score as 
well as the RUM and RAV scale, a separate analysis in women was conducted including the 
heterozygotes to study these interaction effects in detail.
Main effects
We found a significant main effect of MAOA genotype for the LEIDS-R total score (F(1, 326) 
= 3.17; P = 0.04, partial η² = 0.02) and visual inspection suggested a dose–effect relationship. 
Subsequent post hoc Tukey’s tests did not reveal significant group differences between the 
HH, HL, and LL group, but women with the HH genotype tended to have higher LEIDS-R 
total scores than women with the LL genotype (P = 0.099). An analysis at the allele level (LL, 
HL vs. HH) showed a trend toward greater aggression reactivity scores in women who were 
homozygous for the H allele compared with those with one or two L alleles (F(1, 328) = 3.40, 
P = 0.07, partial η² = 0.010). Such effects were not observed on the other primary outcome 
measures. Analyses of the secondary outcome measures showed a significant difference 
between genotypes on the RAV reactivity subscale (F(1, 326) = 3.20; P = 0.04, partial η² = 
0.01), although the post hoc group comparisons were not significant. No other effects of 
genotype were found.
Interaction effects 
No interaction effects were found.
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Discussion
The aim of this study was to investigate the role of the MAOA gene and its interaction with 
childhood trauma and sex on measures of trait and state-dependent aggression- related 
behaviors in a healthy young adult sample. We found that women with the MAOA-HH 
genotype scored higher on some measures of aggression compared with MAOA-LL women. 
Specifically, MAOA-HH women reported more aggressive thoughts and behavior in relation 
to sad mood (LEIDS-R AGG scale) compared with MAOA-LL women. Such effects on the 
LEIDS-R AGG scale did not occur in men, nor did we see any effects on more general trait 
and state measures of aggressive behaviors such as the STAXI. This discrepancy between 
the results on the LEIDS-R and the STAXI may be explained by the fact that the STAXI 
contains two separate scales for state and for trait, whereas the LEIDS-R measures aggression 
in the context of dysphoria. The notion that the effects of MAOA genotype may be context 
dependent is consistent with an experimental study in healthy males (Mcdermott, R. et al., 
2009). Using an aggression provocation task, it was found that the impact of the MAOA-L 
variant on aggressive behavior in males was largest in the context of aggression provocation 
(Mcdermott, R. et al., 2009). The presently found sex-specific effects and their direction are in 
line with Sjöberg et al. (2007), who reported more criminal behavior in MAOA-HH adolescent 
girls with higher psychosocial risk compared with adolescent girls without this risk. Our 
study is a first in showing an association between the high-expression MAOA variant and 
aggression-related behaviors in adult women. Sjöberg et al. found only effects in girls with 
higher levels of psychosocial adversity, whereas in our sample, the effects were irrespective of 
childhood trauma history. Differences in the type of childhood trauma measured (Sjöberg: 
multifamily housing and sexual abuse; current study: emotional and physical neglect and 
abuse, sexual abuse) may account for the discrepancies in findings between the studies. We 
also found sex-specific effects of the MAOA-H variant on total LEIDS-R score, RAV and RUM. 
RUM is known to predict higher levels of depressive symptoms, recurrence of depressive 
episodes, as well as chronicity (Nolen-Hoeksema, 1991, Robinson and Alloy, 2003). Antypa 
et al. (2010) found higher scores on the LEIDS-R total score as well as on the RUM scale 
in healthy individuals who are carriers of the s allele of the serotonin transporter promoter 
polymorphism, a genotype commonly associated with depression (Du et al., 1999, Kaufman et 
al., 2006). We observed one significant three-way interaction of sex, genotype, and childhood 
trauma on the LEIDS-R RAV scale. Specifically, an association between risk aversion scores 
and the high MAOA expression variant was found only in women with a history of childhood 
trauma. The RAV scale measures the tendency to avoid not only risk but also interpersonal 
conflict and is the opposite of aggression. As the HH variant of the MAOA genotype is 
associated with increased aggression, we may speculate that the observed association between 
the MAOA-HH variant and risk aversion suggests that in the context of an early adversity, 
increased risk aversion behavior in HH homozygotes may be a compensatory mechanism for 
increased feelings of aggression. Another explanation of increased aggression in combination 
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with increased risk aversion in the context of early adversity is that MAOA-HH girls who 
show more aggression during early childhood may have experienced increased punishment 
for their aggression by their parents or caretakers, thus learning to avoid certain behaviors 
to avoid punishment or abuse. However, we did not have sufficient information to test for 
possible mechanisms accounting for these effects. Individuals who had experienced trauma in 
childhood had higher HOP reactivity scores than individuals without any history of childhood 
trauma, irrespective of sex or genotype. Interestingly, HOP reactivity has been found to be a 
predictor of risk for suicidal ideation or attempt in formerly and currently depressed samples 
(Antypa and Van Der Does, 2010, Williams et al., 2008). In addition, childhood trauma has 
been shown to be a predictor of suicidality (Agerbo et al., 2002, Beautrais et al., 1996, Bernet 
and Stein, 1999, Brent et al., 2002, Dube et al., 2001, Heim and Nemeroff, 2001, Johnson et al., 
1999). Since our sample comprises healthy individuals, this study extends these observations, 
suggesting that childhood trauma may set the stage for tendencies toward thoughts of 
hopelessness. This might in turn lead to suicidal ideation, especially in the context of further 
genetic susceptibility or further stressors. The current study has some limitations, one of them 
being the relatively small number of men in the sample. Therefore, we cannot rule out the 
possibility that the lack of effects in men is due to a type II error. Indeed, Williams et al. 
(2009) found in a healthy sample that MAOA-L men had higher antisocial trait scores than 
men with the MAOA-H genotype, while no such difference was found in women. Notably, 
the majority of Williams’ et al. sample consisted of men (67%). In interpreting our results, 
we should thus consider the possibility that the lack of results in men in the current sample 
may be due to its smaller size. Furthermore, we did not correct for multiple testing. Hence, 
the risk of false-positive observations cannot be ruled out. However, our study had the a 
priori aim to compare different types of aggression measures and their relationship to the 
MAOA genotype. Another limitation is that our aggression measures were all based on self-
report. It would be of interest to extend this study using other measures of aggression such as 
observational measures, diary techniques, or laboratory aggression-induction procedures. A 
strength of this study is that we recruited a sample that was relatively homogeneous in terms 
of age, education, and ethnicity. Furthermore, participants were screened for mental health 
problems before enrolling in the study. However, a disadvantage of our recruitment strategy is 
that university students are likely to score relatively low on violence and aggression compared 
with the general population. Although mean scores on the STAXI (both State and Trait) did 
not differ much from norm scores for this questionnaire, it would be of interest for future 
studies to use the same methods and procedures in a community sample. To summarize, 
this study showed that some of the associations between aggression, genes, and diagnosis 
previously observed in non-adult patient samples can be generalized to healthy young adult 
samples. This is reflected by elevated scores on assessments measuring the tendency to display 
aggressive behaviors/thoughts in a context of sad mood, rather than in behavior or disease 
pattern itself.
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Chapter 4 
Acute tryptophan depletion in remitted depressed 
patients with and without anger regulation 
problems: effects on symptoms, cortisol and 
testosterone
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Abstract
Introduction: Symptoms of anger and aggression occur in approximately 50% of patients 
with major depressive disorder. Both depression and aggression–related symptoms have been 
associated with serotonergic alterations. The current study tested the hypothesis that remitted 
depressed patients with anger regulation problems during their depression (MDD+A) are 
more sensitive to serotonin reductions than remitted depressed patients without anger 
regulation problems (MDD-A), reflected in greater mood and endocrine responses to acute 
tryptophan depletion (ATD).
Methods: 10 MDD+A and 16 MDD-A participants received a 102.5-g (high-dose ATD) and a 
25.7-g (low-dose ATD) amino acid mixture in a counterbalanced, randomized, double-blind 
crossover design. Mood and anger-related symptoms were measured before and after intake 
of the amino acid mixture as were cortisol and testosterone.
Results: High-dose but not low-dose ATD transiently increased depressive symptoms and 
decreased testosterone levels, 7 hours after ATD. Mood-responses to high-dose ATD were 
more pronounced in the MDD+A group than in MDD-A group and were associated with 
ATD-induced decreases in testosterone. ATD did not affect anger or cortisol levels.
Conclusion: Depressed patients with anger regulation problems may have greater serotonergic 
alterations than patients without anger regulation problems. The findings of the present study 
also suggest that depression and testosterone are associated through serotonergic mechanisms.
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Introduction
Symptoms of anger and aggression are very common in patients with major depressive disorder 
(MDD), even though these symptoms are not part of the diagnostic criteria (Van Praag, 2001). 
In the early nineties, Van Praag proposed an angry/anxious subtype of depression which is 
primarily characterized by anxiety and aggression and a low tolerance for stress (Van Praag, 
1992). Since then, a number of studies have investigated related phenotypes. For instance, Fava 
et al. have characterized a subtype of depression based on the presence of anger attacks (Fava 
and Rosenbaum, 1998, 1999). Anger attacks are defined as sudden spells of anger associated 
with a surge of autonomic arousal accompanied by symptoms such as tachycardia, sweating, 
flushing and a feeling of being out of control (Fava et al., 1990). They are present in about 
40% of depressed outpatients (Fava et al., 1997, 1993, Fava and Rosenbaum, 1999). Irritability 
was present in about half of depressed outpatients in two independent studies (Verhoeven 
et al., 2011, Fava et al., 2009). Both putative subtypes (with irritability or anger attacks) are 
distinct from MDD without these problems on a number of clinical characteristics including 
greater levels of anxiety, somatization and suicidality (Fava et al., 2009, Fava et al., 1993, 
Verhoeven et al., 2011). The clinical relevance of irritability for development of depression 
was demonstrated in a longitudinal study in adolescents, which showed that irritability at 
age 15 was a stronger predictor of depression than of delinquency (both assessed at age 17) 
and that the link between irritability and depression may be largely mediated by common 
underlying biological mechanisms (Stringaris. et al., 2012).
Alterations in serotonin (5-HT) neurotransmission are a consistent finding in depression, as 
indicated by various direct and indirect markers of 5-HT function (Maes and Meltzer, 1995, 
Belmaker and Agam, 2008). Decreased 5-HT function is also present in MDD patients in 
remission (Smith et al., 1997, Neumeister et al., 2002, Yatham et al., 2012). More pronounced 
5-HT alterations have been observed in currently depressed patients with anger attacks 
(Fava et al., 2000) compared to depressed patients without anger attacks, as indicated by 
neuroendocrine challenge procedures. 5-HTergic alterations were also observed in in remitted 
MDD patients with suicidal ideation or behavior during the previous depressive episode 
(Booij et al., 2002, 2006), as shown by greater symptom responses to Acute Tryptophan 
Depletion. Whether 5-HT alterations in MDD patients with anger problems persist beyond a 
depressive episode and how these alterations are associated with anger symptoms and anger-
related cortisol and testosterone responses is not known.
The aim of the current study was to test the hypothesis that remitted depressed patients 
with anger problems during their depression have greater 5-HT impairments than remitted 
depressed patients without anger problems. 5-HT functioning was induced by acute 
tryptophan depletion (ATD), a method that transiently lowers plasma concentrations of the 
precursor of 5-HT, L-tryptophan (Trp). This allows the investigation of the causal effects of 
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lowered serotonin function in an experimental design (Booij et al., 2003, Delgado et al., 1990, 
Moreno et al., 2010, Young et al., 1985).
In addition to mood response, we assessed the effects of ATD on two endocrine measures: 
cortisol and testosterone. Cortisol has been associated with anger problems in MDD (Van 
Praag, 2002, 1996). Testosterone has frequently been linked to anger and aggression regulation 
(Archer, 2006, Mehta and Beer, 2009, Persky et al., 1971, Van Honk et al., 1999, Caramaschi 
et al., 2012). Moreover, both have been shown to interact intensively with the 5-HT system 
(Cowen, 2002, Strickland et al., 2002, Way and Taylor, 2010, Kuepper et al., 2010, Montoya et 
al., 2012). Hypothesizing that depressed patients with anger problems are more sensitive to 
5-HT alterations than patients without anger problems, we expected that mood and endocrine 
responses to ATD would be greater in remitted depressed patients with anger problems than 
in remitted depressed patients without anger problems.
Methods
Participants
Participants were recruited via local mental health institutions and advertisements in local 
newspapers and university buildings. Inclusion criteria were: age between 18 and 65 years; 
meeting DSM-IV criteria for past depression; in remission for at least 2 months and a 
Hamilton Depression Rating Scale (HDRS; Hamilton, M., 1960) score < 10 or Montgomery 
Åsberg Depression Rating Scale (MADRS;(Montgomery, S. A. and Åsberg, M., 1979) score < 
12. Exclusion criteria were: major physical illness; substance abuse and/or dependence within 
the last 3 months; lifetime psychosis; pregnancy, lactation.
High-dose and low-dose ATD
Participants received a 102.5-g (high-dose ATD) or a 25.7-g (low-dose ATD) amino acid 
(AA) mixture in a counterbalanced, randomized, double-blind crossover design, as in our 
previous studies (Booij et al., 2006, Merens et al., 2008). A protein-low lunch was served 
(Booij et al., 2005a, Riedel et al., 1999) at each test session, approximately 3 hours after the 
intake of the AA mixture.
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Measures during the test sessions
Behavior
Symptoms were assessed with the MADRS (Montgomery and Åsberg, 1979) and the HDRS 
(Hamilton, 1960). Sleep items were omitted. Anger was assessed using the Anger Expression 
Inventory (Forgays et al., 1997, Spielberger et al., 1983).
Saliva
Saliva samples were collected using Salicaps (2.0 ml, IBL International) at 4 time-points 
during each testing day (before ingestion of the AA mixture, + 1.5hrs, + 4hrs, + 7hrs). 
Before each saliva-collection, participants cleared their mouths with water and then had to 
refrain from eating and drinking for 30 minutes. Saliva samples were stored at -20°C until 
assayed at the laboratory of biopsychology at the University of Dresden, Germany. Free 
cortisol and testosterone concentrations in saliva were measured using a commercially 
available ’Luminescence Immunoassay for the in-vitro-diagnostic quantitative determination 
of cortisol in human saliva and serum’ and ’Luminescence Immunoassay for the in-vitro-
diagnostic quantitative determination of testosterone in human saliva and serum’ (IBL, 
Hamburg, Germany), respectively. The intra and interassay coefficients of variance for 
cortisol was below 8%. The intra and interassay coefficients of variance for testosterone was 
below 10%.
Amino acids
Venous blood was obtained (10 ml) from all participants using EDTA tubes to assess total 
plasma tryptophan and the ratio to its other large neutral amino acids (LNAAs) and processed 
and analyzed as in our previous studies (Booij et al., 2005a;, see also Fekkes et al., 1995). Since 
the size of the reductions of both tryptophan levels and the ratio of tryptophan to the other 
amino acids following adequate intake and tolerance of high and low-dose ATD have been 
well-documented (at 80-90% and 40-50%, respectively) and have relatively small variability 
(Booij et al., 2006, 2005a, Merens et al., 2008, Spillmann et al., 2001), these manipulation 
checks were only determined for participants who had vomited during an ATD session.
Procedure
The study was approved by the medical ethics committee of the Leiden University Medical 
Center (LUMC) and all participants gave written informed consent before the start of the 
intake session.
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After expressing interest in participation, all eligible participants received written information 
about the study by mail or e-mail. Following a brief telephone interview to verify initial in- 
and exclusion criteria, patients were invited for an intake session. During this session, the 
Structured Clinical Interview for DSM-IV (SCID-IV) (First, Spitzer, Gibbon, & Williams, 
1995) was conducted to verify past and present psychiatric diagnoses. The MADRS and the 
HRSD were used to assess depressive symptoms occurring in the past week. Anger status was 
determined in a clinical interview. This clinical interview consisted of questions regarding 
anger-related cognitions and behaviors during the participant’s depression, based on the 
Anger Attacks Questionnaire (AAQ) (Fava et al., 1991) and included questions like: ‘Did you 
feel more easily angered or more irritable during your depression?’ and ‘Did you physically 
or verbally attack people?’. Participants who reported persistent or repetitive thoughts and 
feelings of anger during their depressive episodes and who reported at least one example of 
angry behavior (such as yelling, throwing things or physically attacking others) were assigned 
to the MDD+A group. Those who denied such cognitions and behaviors were assigned to 
the MDD-A group. Inter-method reliability of the group classification was confirmed by its 
association with self-report measures of anger completed during the intake session, including 
the State Trait Anger Expression Inventory (STAXI; Forgays et al., 1997, Spielberger et al., 
1983) and the Buss-Perry Aggression Inventory (Buss and Perry, 1992) (see also: Table 1.). 
The intake-session was administered as closely to the first ATD session as possible, preferably 
within two weeks.
For the ATD sessions, participants arrived at the lab in the hospital at 9 AM after an overnight 
fast. Upon arrival, a blood sample was taken as well as a saliva sample. The MADRS was 
administered to measure baseline depression symptoms. Patients filled in the STAXI state 
questionnaire to measure their current anger symptoms. Next, participants ingested the 
AA-mixture within half an hour. For the next 4.5 hours (+4.5 hours) patients remained in a 
private research room. Saliva samples were taken 1.5, 4 and 7 hours after the intake of the AA 
mixture (+1.5 hours, +4 hours, +7 hours, respectively). A cognitive test battery was completed 
between +4.5 hours and +6 hours (data not described here). Symptoms were re-assessed using 
the MADRS at +6.5 hours followed by a blood sample. At the end of the session, participants 
received a snack to facilitate normalization of AA-levels. This procedure was repeated at 
least one week later; those who had received the high-dose ATD in the first session received 
low-dose ATD in the second session and vice versa. Each participant received €180 for 
participation. Both the participant and the researcher were blind for the order of the high- 
and low-dose ATD. The AA mixture was prepared by the hospital pharmacology department.
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Statistical Analyses
Group differences in demographic and clinical characteristics were investigated by means of 
chi-square tests and univariate analysis of variance (ANOVA) using general linear models 
(GLMs).
Separate repeated-measures multivariate analyses of variances were conducted to investigate 
the effects of the two different doses of ATD on mood, anger and psychophysiology in the two 
different groups. For mood and state anger, intervention (low dose vs. high dose) and time 
(before ingestion vs. + 7 hours) were the within-subjects factors. Anger status in depression 
was used as a between-subjects factor. A similar analysis was conducted for the endocrine 
measures, using the values before ingestion and +7 hours (when Trp levels are expected to be 
at their minimum) as time factor.
More detailed analyses for the endocrine measures were performed by calculating the area 
under the curve with respect to the ground (AUCg) as well as the area under the curve with 
respect to the increase (AUCi). The AUCg and AUCi will provide an indication of hormonal 
secretion over the day versus the change over time throughout the day, respectively (Pruessner, 
J. C. et al., 2003). These AUCs were analyzed using ANOVAs to compare the AUCs with 
anger status as a between subjects factor. Delta-scores for psychophysiology measures and 
mood at +7 hours vs. before ingestion of ATD mixture (Δ cortisol and Δ testosterone) were 
also calculated to examine intercorrelations. Testosterone and cortisol values were log10 
transformed to achieve normality of the data.
Mood response to high dose ATD was defined as the MADRS score 6 hours after high dose 
ATD minus the MADRS score just before high dose ATD.
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Table 1
Demographic and clinical characteristics of remitted depressed patients with (MDD+A) 
and without (MDD-A) anger problems during depression
MDD + A (n = 10) MDD – A (n = 16) p
Age (mean±SD) 26.9±8.1 25.9±9.3 .79
Sex (male/female) 2/8 6/10 .42 ¶
Smoker (yes/no) 2/8 4/12 > .99 ¶
Antidepressant use (yes/no) 5/5 4/12 .19 *
Nr. of previous episodes
 single/recurrent 2/8 4/11^ .70
¶
Suicidality (ever; yes/no) 7/3 13/3 .51 ¶
MADRS intake (mean±SD) 3.4±4.3 2.8±2.7 .64
STAXI (mean±SD)
 Trait 22.0±5.5 15.5±4.0 .002
*Pearson’s chi-square test for antidepressant use (yes/no) vs. anger in depression (yes/no)
¶(Fisher’s Exact Test)
^ 1 missing value in MDD-A group




For an overview of participant enrollment see Figure 1.
Six of the 28 participants who completed the experimental procedures vomited on at least 
one of the testing days. We excluded one participant who had vomited during the high-dose 
ATD session based on the fact that she had a decrease of plasma Trp of only 42% on that 
day, whereas a reduction of 75%-90% is expected for high-dose and 40-50% for low-dose 
ATD (Krahn et al., 1996, Spillmann et al., 2001 , Booij et al., 2005a, Merens et al., 2008,). In 
the other participants who vomited during high-dose ATD, the decrease in Trp levels was 
at least 74%. In another participant, baseline depression scores (MADRS: 18) were higher 
than the inclusion criteria allowed (MADRS: 12), due to a procedural error. This participant 
completed both sessions but was left out from the analyses because ATD responses in 
symptomatic depressed patients are highly variable and bimodal (Booij et al., 2005c). Hence, 
26 participants, 10 MDD+A and 16 MDD-A, were included in the analyses.
Demographic and clinical measures
No significant differences on demographic or clinical characteristics other than anger and 
aggression symptoms were found between remitted depressed patients with and without 
anger problems during depression (Table 1).
Mood
As hypothesized, high-dose ATD led to a greater increase in depressive symptoms than low-
dose ATD [F(1, 24) = 12.351, p = .002] (see Figure 2). Furthermore, the increase in MADRS-
scores during the high-dose ATD condition tended to be larger in the A+ group than in the 
A- group, as shown by a trend level group by intervention by time interaction [F(1,24) = 3.53, 
p = .072]. Specific contrast tests between the conditions showed that high-dose ATD induced 
a significant increase in MADRS scores [F(1,24) = 8.50, p = .008] in the MDD+A group only. 
Since previous studies have shown that the use of 5-HTergic antidepressant medication is 
predictive of mood response to ATD (Booij et al., 2002, Delgado et al., 1990, Delgado et al., 
1999) and some of our patients in the A+ group were on 5-HT antidepressants (although 
not a significantly higher number than patients in the A- group), a hierarchical multiple 
regression analysis was performed to investigate the unique contribution of anger problems 
during depression on mood response to ATD, while controlling for the use 5-HTergic 
antidepressants. Current 5-HTergic antidepressant medication use was entered in the first 
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Flow-chart of participant enrollment with drop-out and exclusion rates per phase of the study
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block, followed by ‘anger problems during depression’ in a second block. This analysis showed 
that anger during depression was associated with mood response to ATD (standardized beta 
= .455, t = 2.533, p = .019), also when 5-HTergic antidepressant medication was controlled for 
(standardized beta = .221, t = 1.232, p = .230).
Anger 
No effects of intervention, time or intervention by time were found on trait and state anger 
(STAXI), nor were there any interactions with anger status.
Testosterone
Testosterone levels were significantly lower at +7 hours compared to baseline [F(1,24) = 
17.57, p < .001]. We also found a significant intervention by time interaction. Notably, there 
was a greater decrease in testosterone levels in the high-dose than in the low-dose condition 
[F(1,24) = 6.27, p = .019] (Figure 3). No interaction with anger status was found. No effects 
of dose, time or dose by time were found on the AUCg or AUCi for testosterone, nor were 
there any interactions with anger status. The increase in depressive symptoms in the high-
dose condition correlated with the decrease of testosterone in the MDD+A group (Pearsons 
r = -.72, p = .019). This association was not observed in the MDD-A group (Figure 4a and 
Figure 4b).
A negative Pearson’s r value indicates an association between increases in MADRS scores and 
decreases in testosterone levels.
Cortisol
Cortisol levels were significantly lower at +7 hours compared to cortisol levels before ATD 
[F(1, 24) = 130.98, p < .001]. However, we did not find any interactions with intervention or 
anger status. No effects of intervention, time or intervention by time were found on the AUCg 
or AUCi for cortisol, nor were there any interactions with anger status.
Discussion
The current study investigated the effects of low- versus high-dose ATD on mood, testosterone 
and cortisol in remitted depressed patients who had or had not experienced anger problems 
during their depression. Consistent with previous studies, high-dose ATD increased 
depressive symptoms and low-dose ATD did not (Booij et al., 2005a, Merens et al., 2008). 
In line with our hypotheses, the increase was greater in remitted depressed patients who had 










































Mood scores before (morning) and after (+6.5h; afternoon) low- and high-dose ATD. Data 
represent mean-scores ± SE for both MDD+A and MDD-A.
Figure 3
Testosterone levels before (morning) and after (+7h; afternoon) low- and high-dose ATD. 
Data represent mean-scores ± SE
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The correlation between mood response and change in testosterone-levels (Δ testosterone = 
+7h testosterone levels – morning testosterone levels) in the MDD-A group.
A negative Pearson’s r value indicates an association between increases in MADRS scores 
and decreases in testosterone levels
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The correlation between mood response and change in testosterone-levels (Δ testosterone = 
+7h testosterone levels – morning testosterone levels) in the MDD+A group. 
A negative Pearson’s r value indicates an association between increases in MADRS scores 
and decreases in testosterone levels
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experienced anger problems (MDD+A) compared to those who had not experienced anger 
problems (MDD-A).
This greater mood response to ATD in patients whose prior depression had been characterized 
by impulse dysregulation is in line with previous studies (Booij et al., 2002, Booij et al., 2006, 
Leyton et al., 2000), showing that mood response to ATD was larger in individuals with 
strong suicidal ideation during their depression. It is reasonable to assume that the crucial 
distinction is impulsive behavior, but the current sample size was insufficient to make a direct 
comparison between patients characterized by anger vs. characterized by suicidality during 
their depressive episode.
With regard to the endocrine responses to ATD, high-dose ATD significantly lowered 
testosterone levels at the time that Trp levels were lowest, whereas low-dose ATD did not. In 
the MDD+A group but not in the MDD-A group, the testosterone response to ATD correlated 
with mood response to high-dose ATD. The finding that ATD lowers testosterone is consistent 
with diminished testosterone levels commonly observed in depressed patients (Zarrouf et al., 
2009, Giltay et al., 2012). Administration of testosterone may have antidepressant effects in 
some patients such as older depressed males (Zarrouf et al., 2009). We are not aware of other 
studies that investigated the effects of ATD on testosterone. The findings of the present study 
suggest that depression and testosterone are associated through serotonergic mechanisms.
Contrary to our hypothesis, ATD did not increase anger symptoms. Moreover, ATD did 
not induce the endocrine responses that commonly co-occur with anger such as increased 
testosterone and cortisol (Harris, 1999, Van Bokhoven et al., 2005). The lack of effects on 
anger measures suggests that the behavioral response to ATD in remitted depressed patients 
is primarily expressed in the core symptoms of depression such as low mood and anhedonia 
(Booij et al., 2005b). These core symptoms may obscure or even counteract an anger response 
to ATD. In other words, although high-dose ATD affects MDD+A patients to a greater 
extent than MDD-A patients, anger symptoms may be associated with a different biological 
mechanism of depression which was not addressed by ATD. Alternatively, the questionnaires 
may not have been sensitive enough or the laboratory environment may have been too ‘neutral’ 
to measure the effects of ATD on anger symptomatology. For future ATD studies in MDD+A 
patients, it would be of interest to include a provocation task to elicit an anger-response.
The pros and cons of the ATD design using low-dose ATD as the control condition instead 
of the more often used amino acid mixture containing Trp as placebo, have been discussed 
previously (Booij et al., 2006, 2005a, Merens et al., 2008). Although the sample size was in line 
with our other ATD studies in remitted depressed patients, the study would have benefited 
from a larger sample, especially in the MDD+A group, allowing to investigate higher order 
interactions between ATD response, anger status and other clinical and demographic 
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characteristics known to predict mood response, including recurrent depression, suicidality 
and female sex (Booij et al., 2002). Finally, our patient sample was rather heterogeneous in 
terms of medication status. Although previous studies have found greater effects of ATD in 
remitted depressed patients using selective serotonin reuptake inhibitors (SSRI) compared 
to noradrenergic antidepressant medication (Delgado et al., 1990, Delgado et al., 1999), a 
reanalysis of several ATD studies showed that other factors such as sex and previous suicidal 
ideation were better predictors of mood reaction to ATD than the use of medication. This 
was especially the case for those patients who had already been in remission longer (Booij et 
al., 2002), as is the case in the current study. Moreover, the MDD+A and MDD-A group did 
not differ in medication status, neither did the results change when use of medication was 
controlled for, making it less likely that medication has confounded the results. Nevertheless, 
it would be of interest to redo the study in an unmedicated sample.
The current study is a first to compare 5-HT function and associated symptom and endocrine 
responses in patients with and without anger symptoms during their depression, using ATD. 
In previous studies (Verhoeven et al., 2011, Fava et al., 20010, Fava and Rosenbaum, 1998) it 
was shown that MDD patients with anger or irritability differ on many behavioral and clinical 
characteristics. In the present study, we found some indications of greater serotonergic 
vulnerability in patients whose depression is accompanied by anger symptomatology. 
Longitudinal studies are needed to further investigate the clinical relevance of our findings in 
terms of relapse rates and treatment response. 
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Abstract
Introduction: Anger and irritability occur in up to 40% of depressed patients. Moreover, 
both depression and anger and irritability have been associated with serotonergic (5-HT) 
function. The aim of the present study was to investigate serotonergic mechanisms in 
relation to impulsivity and anger-related emotion-cognitive processes in depression, using 
acute tryptophan depletion (ATD). More specifically, we investigated the effect of ATD on 
impulsivity and emotion processing in remitted depressed patients with anger regulation 
problems during their depression (MDD+A) versus remitted depressed patients without 
anger regulation problems (MDD-A).
Methods: 10 MDD+A and 16 MDD-A participants (8 male, 18 female, mean age±SD: 
26.3±8.7) received a 102.5-g (high dose ATD) and a 25.7-g (low dose ATD) amino acid 
mixture in a counterbalanced, randomized, double-blind crossover design. Cognitive tasks 
included the Immediate Memory Task (IMT) and GoStop task for impulsivity and the Facial 
Expression Recognition Task (FERT) and Approach Avoidance Task (AAT) for emotion 
processing. All tasks were measured after both low and high dose ATD and compared to a 
baseline measurement.
Results: On the IMT, we found a decrease in impulsivity after low dose ATD for all participants. 
We also found a decrease in the discrimination of target stimuli from other stimuli after low 
dose ATD for all participants (i.e. an increase of commission errors), but no further significant 
changes in either impulsivity or discriminability after high dose ATD. No differences in 
impulsivity between MDD+A and MDD-A were found, nor were there any interactions of 
anger status with ATD. No effects of intervention, anger status or any interactions were found 
on the emotion processing tasks.
Discussion: Using ATD, the current study did not provide strong support for the involvement 
of serotonergic mechanisms in impulsivity and processing of emotional faces in depression. 
Results might be (partly) explained by individual clinical differences in disease course or 
treatment or by task sensitivity. These factors should be taken into account in future studies.
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INTRODUCTION
Up to 40% of patients with major depressive disorder (MDD) experience some form of anger-
related problems (Van Praag, 2001), ranging from irritability (Perlis et al., 2009, Fava et al., 
2009, Verhoeven et al., 2011) to anger attacks (Fava et al., 1997, Fava et al., 1993, Fava and 
Rosenbaum, 1999). Patients with MDD and irritability or anger attacks differ from MDD 
patients without these problems on a number of clinical characteristics, including more severe 
anxiety, somatization and suicidality and a higher cognitive reactivity to sad mood (Fava et al., 
2009, Fava et al., 1993, Verhoeven et al., 2011). In order to investigate one of the underlying 
biological mechanisms of this putative subtype, we used Acute Tryptophan Depletion (ATD) 
to lower serotonin (5-HT) function temporarily, thereby aiming to identify the causal role 
of 5-HT in the development of anger in depression. As discussed in Chapter 4 of this thesis, 
remitted depressed patients with anger regulation problems during their previous depressive 
episode (MDD+A) had a more pronounced mood response to ATD than remitted depressed 
patients without these problems (MDD-A). This suggests that the MDD+A group is more 
sensitive to 5-HT alterations than the MDD-A group.
Lower 5-HTergic function is also associated with impulsivity, although findings from studies 
using ATD have been mixed. In some studies increased impulsivity was observed in response 
to ATD in healthy participants (Crean et al., 2002, Dougherty et al., 2010, Walderhaug et 
al., 2002), but not in others (Chen and Bargh, 1999, Clark et al., 2005, Evers et al., 2006). 
One study found that sex moderates the response to ATD, with an increase of impulsivity in 
men and a decrease in women (Walderhaug et al., 2010). ATD in remitted depressed patients 
increased impulsivity, but only in a subgroup characterized by suicidal ideation during their 
prior depression (Booij et al., 2006).
Not only impulsivity is associated with depression; depressed patients also show a bias 
towards negative information as indicated by various cognitive tasks (Gur et al., 1992, Burt 
et al., 1995, Bouhuys et al., 1999, Elliott et al., 2011, Gotlib and Mccann, 1984, Gollan et 
al., 2008, Mikhailova et al., 1996, Segal et al., 1995, Surguladze et al., 2004). This bias partly 
persists after remission from depression (Bhagwagar et al., 2004, de Raedt and Koster, 2010, 
Hayward et al., 2005, Joormann and Gotlib, 2007). Remitted depressed patients have shown 
some persisting bias for emotional stimuli such as fearful faces in response to high dose ATD 
(Merens et al., 2008b), but another study by Merens et al. (2008a) suggests that biases found 
during depression may have become latent and will only be active after being triggered. The 
study by Merens et al. (2008a) found a bias for fearful faces in remitted depressed patients, but 
only after high dose ATD. Other studies using ATD also found evidence for a role of 5-HT in 
these emotional biases (Munafò et al., 2006, Elliott et al., 2011, Hayward et al., 2005, Booij et 
al., 2005c).
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One model that links 5-HTergic function and cognitive changes in depression is the two-mode 
model of depression proposed by Carver et al. (2008). This model states that decreased levels 
of 5-HT can result in loss of effortful control over reactive systems of approach of reward and 
avoidance of punishment. What happens when 5-HT decreases and effortful control is lost, 
depends on which system is most dominant at that time. The result can be either increased 
avoidance of cues associated with punishment, as is the case in depression, or increased 
reward approach, resulting in impulsivity. In light of this model, we expect ATD to increase 
depressive symptomatology in the both groups, but impulsivity only in the MDD+A group.
The aim of the present study was to investigate serotonergic mechanisms in relation to 
impulsivity and emotional face processing, including those relevant for anger regulation, 
using ATD. We examined remitted depressed patients with and without anger regulation 
problems during their depression. We hypothesized that ATD would increase impulsivity in 
MDD+A but not in MDD-A. Based on the results of one of our previous ATD studies in 
remitted MDD patients (Merens et al., 2008a), we also hypothesized that high dose ATD 
would alter the recognition of sad and fearful faces in both MDD groups. In the present 
sample, we further expected that MDD+A patients would be faster in the processing of angry 
faces, consistent with their clinical profile. Specifically, we expected the MDD+A group to 
approach angry faces more often compared to avoidance of angry faces in the MDD-A group.
Methods 
Participants
Participants were recruited via local mental health institutions and advertisements in 
local newspapers and university buildings. Inclusion criteria were: age between 18 and 65 
years; meeting DSM-IV criteria for past depression; in remission for at least 2 months and 
a Hamilton Depression Rating Scale (HDRS Hamilton, 1960) score < 10 or Montgomery 
Åsberg Depression Rating Scale (MADRS; Montgomery and Åsberg, 1979) score < 12, the 
same as in our previous studies (Booij et al., 2006, 2005a). Exclusion criteria were: major 
physical illness; substance abuse and dependence within the last 3 months; lifetime psychosis; 
pregnancy, lactation.
During intake, anger status was determined in a clinical interview, which consisted of questions 
regarding anger-related cognitions and behaviors during the participant’s depression, based 
on the Anger Attacks Questionnaire (AAQ) (Fava et al., 1991) and included questions like: 
‘Did you feel more easily angered or more irritable during your depression?’ and ‘Did you 
physically or verbally attack people?’. Participants who reported persistent or repetitive 
thoughts and feelings of anger during their depressive episodes and who reported at least one 
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example of angry behavior (such as yelling, throwing things or physically attacking others) 
were assigned to the MDD+A group. Those who denied such cognitions and behaviors 
were assigned to the MDD-A group. Inter-method reliability of the group classification was 
confirmed by its association with self-report measures of anger completed during the intake 
session, including the State Trait Anger Expression Inventory (STAXI; Forgays et al., 1997, 
Spielberger et al., 1983) and the Buss-Perry Aggression Inventory (Buss and Perry, 1992) (see 
also: Table 1. in Chapter 4).
High dose and low dose ATD
Participants received a 102.5-g (high dose ATD) or a 25.7-g (low dose ATD) amino acid (AA) 
mixture in a counterbalanced, randomized, double-blind crossover design, as in our previous 
studies (Booij et al., 2006, Merens et al., 2008a). A protein-low lunch was served (Booij et al., 





The Immediate Memory Task (IMT) (Dougherty et al., 2003, Dougherty et al., 2002) used 
was derived from the continuous performance task (CPT) (Cornblatt et al., 1988). In this 
10-minute task, series of five-digit numbers were presented consecutively on the computer 
monitor for 500 ms with a 500 ms inter-trial interval. Participants were instructed to respond 
by mouse click to each series identical to the one that preceded it. Three main dependent 
variables were obtained: 1) correct detections, 2) commission errors, where the participant 
incorrectly responded to a 5-digit number that differed from the preceding number by 
only one digit, 3) response latencies, which is the time in milliseconds between stimulus 
presentations and the participant’s recorded responses. The IMT is used to measure the 
impulsivity of response initiation. Several dependent measures for this task were calculated: 
the parametric and non-parametric measures for Discriminability (d’, A’) and Response Bias 
(β, β”d) as well as the IMT Ratio, which is the proportion of commission errors relative to 
the correct detections (Dougherty et al., 2009, Dougherty et al., 2002). Discriminability 
represents the discrimination of target stimuli from other stimuli; Response Bias is the index 
of impulsive versus cautious decision-making. Since our main interest was impulsivity and we 
expected results to be distributed normally, our main variable of interest was the parametric 
measure of Response Bias β.
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GoStop 
The GoStop was used to measure response inhibition. Series of 5-digit numbers were displayed 
for 500 msec with a 1500 msec inter-stimulus interval. Like the IMT described above, 5-digit 
numbers appeared in series, and some of these series were identical to the immediately 
preceding 5-digit series. Participants were instructed to respond to these matching numbers 
(the ‘go’ signal). However, some of these matching series were first presented in black and 
would then turn red. This was the ‘stop signal’, and participants were instructed to withhold 
their response to series turning red. The timing of these stop signals varied across the testing 
session (50, 150, 250 and 350 ms). The two dependent measures of interest for this task were: 
1) correct responses, 2) response inhibition failures, where the participant failed to withhold 
responding to a matching number when a stop signal had appeared. The primary dependent 
measure was the GoStop Ratio, which was calculated as the number of response inhibition 
failures (i.e. incorrect responses to stop trials) relative to the number of correct responses (i.e. 
go trials). Data from the 150 ms stop delay typically provide the best group discrimination 




The Facial Expression Recognition task (FERT) measured the ability to detect emotions 
(Joormann and Gotlib, 2006). Pictures from the Ekman-database (Ekman and Friesen, 1976) 
of four basic emotions – happiness, sadness, anger and fear – were morphed from a neutral 
expression to the full expression of an emotion in increments of 2%. For each emotion, one male 
and one female face were used. Presenting each face for 500ms, a movie-like representation of 
the transition between neutral and emotional facial expression was created. Participants were 
instructed to react to the stimuli by pressing a key as soon as they recognized the emotion, 
after which they had to indicate which of the four emotions they had recognized. As primary 
outcome measures we looked at average reaction time (expressed by the average Intensity 
at which an emotion was recognized) and correct responses (Accuracy) for each emotion, 
especially sad and fearful faces.
AAT 
In general, negatively valenced stimuli (e.g. fearful faces) are associated with avoidance 
behavior and positively valenced stimulus (e.g. smiling faces) are associated with approach 
behavior (Chen and Bargh, 1999). However, although anger is seen as a negative emotion, 
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one previous study showed angry faces to elicit approaching behavior (Horstmann, 2003). 
To measure approach/avoidance reactions to emotional stimuli, the Approach Avoidance 
Task (AAT) (Heuer et al., 2007) was administered. During this task, participants were asked 
to respond to either light yellow or grey-colored angry, happy, disgusted or neutral faces. 
Participants were asked to push away the yellow faces and pull the grey faces towards them 
using a joystick. Faces increased in size when the joystick was pulled and decreased in size 
when the joystick was pushed away, disappearing upon complete execution of the correct 
response.
Outcome measures were the AAT effect scores or AAT ratios (reaction time (RT) push – RT 
pull) for movement initiation (RT1) and movement completion (RT4) calculated separately 
for each emotion; this way, positive scores reflected relative approach and negative scores 
reflected relative avoidance of a certain emotion.
Procedure
The study was approved by the medical ethics committee of the Leiden University Medical 
Center (LUMC) and all participants gave written informed consent before participation. 
Remitted depression was established through conduction of the Structured Clinical Interview 
for DSM-IV (SCID-IV) (First, Spitzer, Gibbon and Williams, 1995) during an intake session. 
At the end of the intake session, participants performed the cognitive tasks. On testing days, 
venous blood was taken in the morning and +6h after ATD. Mood was assessed before 
ATD as well as +6.5h after ATD. The cognitive tasks (IMT, GoStop, FERT and AAT) were 
administered +4.5h after ATD. Order of high and low dose ATD was counter-balanced over 
all participants.
Statistical analysis
Group differences in demographic and clinical characteristics were investigated by means of 
chi-square tests and univariate analysis of variance (ANOVA) using general linear models 
(GLMs).
The effects of ATD on impulsivity and emotional processing were investigated using GLM for 
repeated measures, with Intervention (baseline vs. low dose vs. high dose) as within-subjects 
factor and group (MDD+A/MDD-A) as between-subjects factor. We used contrast tests to 
investigate specific differences between interventions. For the emotion processing tasks we 
added emotions as within subjects factors (for the FERT: happy, sad, angry and fear; for the 
AAT: happy, angry, disgust and neutral). Baseline for all measures was defined as the mean of 
the intake and the post-intervention session and was used to control for learning effects that 
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might have occurred as a result of repeated administration of the tasks (cf. Booij et al., 2005b). 
Because of its non-normal distribution, accuracy (ACC) scores of the FERT were analyzed 
using nonparametric Friedman’s tests.
Results
Data screening
A total of 28 participants completed all measurements (intake, low and high dose ATD testing 
day and a post-intervention session). As described in Chapter 4 of this thesis, we excluded 
two participants afterwards; one because of insufficient decrease of Trp levels after high dose 
ATD and the other because of a procedural error (i.e. a MADRS-score higher than allowed 
by inclusion criteria).
For two cognitive tasks, intake data for one participant were missing and post-intervention 
data were used as a baseline. Three participants missed the post-intervention session (over 
two tasks) and intake data were used as a baseline.
A more detailed overview of participant enrollment can found in Chapter 4 of this thesis, 
Figure 1.
Participants
No significant differences on demographic or clinical characteristics other than anger and 
aggression symptoms were found between remitted depressed patients with and without 
anger regulation problems during depression (Table 1, Chapter 4).
Symptoms
High dose ATD transiently increased depressive symptoms but low dose ATD did not. 
Symptoms of anger and aggression were however not affected by either high or low dose ATD 
in both groups. See Chapter 4 for more details.
Impulsivity
Results for the cognitive tasks are summarized in Table 2.
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IMT
See also Figures 1a and 1b.
There was a main effect of intervention on measures of Response Bias B [F(2,48) = 5.27, p 
= .008] and B’’d [F(2,48) = 5.35, p = .008] as well as of Discriminability d’ [F(2,48) = 11.37, 
p < .001] and A’ [F(2,48) = 10.49, p < .001] but not on IMT Ratio. Subsequent contrast tests 
showed a significant increase in Response Bias between baseline to low dose ATD for both β 
[F(1,22) = 8.87, p = .007] and B’’d [F(1,22) = 7.94, p = .01], followed by a trend decrease again 
for high dose compared to low dose ATD, for both measures β [F(1,22) = 3.12, p = .091] and 
B’’d [F(1,22) = 3.51, p = .075]). Discriminability differed significantly between from baseline 
and low dose ATD, being lower after low dose ATD than on baseline, but was also lower after 
high dose ATD compared to baseline and in high dose ATD compared to low dose ATD d’ 
(respectively: [F(1,22) = 8.70, p = .007], [F(1,22) = 16.23, p = .001] and [F(1,22) = 4.30, p = 
.05]. The same pattern was visible for A’; baseline vs. low dose ATD: [F(1, 22) = 5.57, p = .028], 
baseline vs. high dose ATD: [F(1,22) = 11.76, p = .002] and low dose ATD vs. high dose ATD 
[F(1,22) = 4.49, p = .046]. No main effects of anger during depression nor any interaction 
effects of anger group (MDD+A/MDD-A) with IMT measures were found.
GoStop




We found a main effect of emotion, with a significantly faster recognition of happy faces 
compared to sad faces [F(1,22) = 105.33, p < .001] as well as significantly fewer mistakes 
on happy faces compared to sad faces [F(1,22) = 36.94, p < .001]. Moreover, fear was 
recognized faster than sadness [F(1,22) = 5.54, p = .028]. However, there were no main effects 
of intervention or anger or higher order interaction effects on any of the FERT outcome 
measures.
AAT
There were no main effects of intervention or group or higher order interaction effects on any 
of the AAT outcome measures (p>.34).
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Error Bars: +/- 1 SE
Figure 1a
Discriminability scores d’ on Baseline, after low dose ATD and after high dose ATD. Data 
represent mean-scores ± SE for all participants taken together.
Figure 1b
Response Bias scores β on Baseline, after low dose ATD and after high dose ATD. Data 
represent mean-scores ± SE for all participants taken together.
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DISCUSSION
The current study investigated the effect of high and low dose ATD on impulsivity and 
processing of emotional faces in remitted depressed patients who had (MDD+A) or had 
not (MDD-A) experienced anger during their depression. We expected to find changes in 
impulsivity and emotion processing, especially those emotions related to anger regulation, 
after ATD in MDD+A compared to MDD-A participants.
Our hypothesis that high-dose ATD would increase impulsivity in MDD+A but not in MDD-A 
could not be supported by our findings. Specifically, we found a decrease in impulsivity in the 
Immediate Memory Task (IMT) (measured by β) after low dose ATD for all participants, 
but no difference between the MDD+A and MDD-A group. We also found a decrease in 
discriminability after low dose ATD for all participants, but no further significant change after 
high dose ATD, nor any further interactions with anger.
A previous study in healthy participants found that sex moderates impulsivity in response 
to ATD, with an increase of impulsivity in men and a decrease in women (Walderhaug et al., 
2010). However, the current study lacked power to make the same comparison.
Booij et al. (2006) found increased impulsivity after high dose ATD in a group of remitted 
depressed patients with previous suicidality. In the present study participants were grouped 
on the basis of anger; comparison of SI+ and SI- (no suicidal ideation during depression) 
groups was not possible because all but six of our participants belonged to the SI+ group. 
Our results differ from these previous findings due to the fact that anger and suicidality may 
represent different 5HT-ergic endophenotypes in depression. Alternatively, differences in 
medication status between the studies may account for the discrepancy in results; whereas 
the current sample consisted of both medicated and unmedicated participants, Booij (2006) 
included only participants using 5-HT antidepressant medication.
Whereas previous studies found decreased recognition of fearful faces after high dose ATD 
(Merens et al., 2008a, Harmer et al., 2003, Beacher et al., 2011) and increased recognition of 
disgusted faces after low dose ATD (Merens et al., 2008a), the current study did not find any 
effects of either low or high dose ATD on emotion processing, nor in the entire group nor 
between the MDDA+ and MDDA- group. This discrepancy in findings could be due to the 
heterogeneity of our current sample, both in terms of medication use (9 out of 26 participants 
were still using antidepressant medication vs. all patients using SSRIs in Merens et al., 
2008a), and in terms of comorbid disorders (several participants had 1 or more comorbid 
disorders such as panic disorder or binge eating disorder). Sampling characteristics caused 
by recruitment for research into ‘depression and anger’ are another unknown and possibly 
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confounding factor in our sample. The current study used yet a different sample than did 
Harmer et al. (2003), Beacher et al. (2011) and Merens et al. (2008a), who investigated healthy 
volunteers (Harmer et al., 2003, Beacher et al., 2011) and remitted depressed patients (Merens 
et al., 2008a), but did not distinguish on anger or suicidality status. This may explain the 
difference in outcome between those studies and the current one.
The pros and cons of the ATD design using low dose ATD as the control condition instead 
of the more often used amino acid mixture containing Trp as placebo, have been discussed 
previously (Booij et al., 2006, Booij et al., 2005a, Merens et al., 2008a). Although the sample size 
was in line with our other ATD studies in remitted depressed patients, the study would have 
benefited from a larger sample, especially in the MDD+A group, allowing to investigate higher 
order interactions between ATD response, anger status and other clinical and demographic 
characteristics known to predict mood response, including recurrent depression, suicidality 
and female sex (Booij et al., 2002).
Future studies into the differences between MDD+A versus MDD-A could benefit from the 
use of anger or stress induction paradigms. In an earlier study by Bjork et al. (2000), ATD 
led to increased aggression in highly aggressive men compared to non-aggressive men in 
response to provocation. Using a provocation paradigm in combination with ATD may be 
more sensitive to detection of cognitive differences between MDD+A and MDD-A. Clinical 
practice could benefit from knowledge that indicates whether anger-related cognitions could 
serve as a marker to differentiate between depression subtypes, as well as the relevance of 
these cognitions for the best choice for and optimal duration of antidepressant treatment.
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Thirty to 40% of depressed patients experience some form of anger regulation problems – 
from irritability (Fava et al., 2009, Perlis et al., 2005) to anger attacks (Fava and Rosenbaum, 
1998, 1999). The aim of the research described in this thesis was to investigate the significance 
of anger regulation problems in the context of depression and the extent to which the presence 
of such problems represents a subtype of depression. This may in turn guide treatment.
We investigated anger regulation problems in depression on different levels including behavior 
and genetic assessments. We also measured clinical characteristics, psychophysiology and 
cognitive aspects.
In the first study, we investigated psychophysiological and clinical characteristics associated 
with anger regulation problems in depression. We did this in a large, well-documented sample 
recruited from a longitudinal cohort study on depression and anxiety (Netherlands Study on 
Depression and Anxiety; NESDA). Subsequently, we investigated possible genetic mechanisms 
(i.e. monoamine oxidase A (MAOA)) associated with anger regulation problems in the context 
of sad mood. We hypothesized that the association between genotype, childhood trauma, and 
aggression would be different for men and women. We tested this hypothesis in a sample 
(N = 432) of college students. Finally, we investigated serotonergic (5-HTergic) mechanisms 
putatively playing a role in anger regulation problems and associated symptomatology in 
depression. We hypothesized that depressed patients with anger regulation problems have 
greater 5-HT alterations than depressed patients without these problems. To test this, we used 
the method of acute tryptophan depletion (ATD) in a sample (N = 26) of remitted depressed 
patients.
Summary of the main findings
To investigate whether irritable depressed patients can be distinguished on other characteristics 
(besides irritability), we used data from a large population based cohort study and compared 
420 currently depressed patients with irritability to 493 currently depressed patients without 
irritability (Chapter 2). We found that irritable depressed patients more often had an anxiety 
disorder and that they scored higher on anxiety symptoms than non-irritable depressed 
patients. A higher percentage of the irritable depressed patients had attempted suicide and 
they scored higher on depression severity, as well as on the personality trait Neuroticism. 
They scored lower on Agreeableness compared to non-irritable depressed patients. After 
correction for depression severity, we did not find differences between irritable and non-
irritable depressed patients on psychophysiology, including measures of HRV, cholesterol and 
cortisol. Since there were no extensive neurobiological measures of included (e.g. measures 
of 5-HT), this study does not allow us to be conclusive on psychophysiological/biological 
differences between depression with and without irritability.
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In Chapter 3, we investigated a possible genetic mechanism for aggression occurring in the 
context of depression in a healthy population. We therefore investigated the association 
between MAOA genotypic variation and aggressive thoughts and behaviors as trait and as 
state phenomena in the context of sad mood. We tested whether the low expression variant 
(as opposed to the high expression variant) of the MAOA genotype was associated with 
cognitive reactivity to sad mood (CR) and trait aggression. CR is a putative cognitive marker 
of depression vulnerability. The scale we used contained a subscale measuring Aggression 
Reactivity (i.e., the tendency to have an increase of aggressive thoughts and behavior during 
periods of dysphoria). Moreover, we investigated the association between the MAOA 
genotype and Aggression Reactivity to sad mood, and its interaction with childhood trauma 
and sex. Women with the high expressing variant of the MAOA gene (MAOA-H) had higher 
aggression reactivity scores than women with the low expressing variant (MAOA-L). This 
association was not observed in men. No associations were found between MAOA variant 
and measures of state and trait anger, nor did we find any evidence for MAOA gene by 
childhood trauma interactions. The results of the study described in Chapter 3 may suggest 
that variation in MAOA gene variants might predispose to anger-related behaviors in the 
context of depression, but only in women.
To investigate differences in 5-HTergic function between depression with and without anger 
regulation problems, we challenged the 5-HTergic system in remitted depressed patients with 
and without anger problems during their depression (MDD+A and MDD-A). We used the 
method of acute tryptophan depletion (ATD) and measured mood response, cortisol and 
testosterone levels (Chapter 4) as well as emotion processing and impulsivity (Chapter 5).
We found that high-dose ATD transiently increased depressive symptoms and decreased 
testosterone levels, 7 hours after ATD. Compared to low dose ATD, symptom response to 
high dose ATD was more pronounced in the MDD+A group than in the MDD-A group. 
Moreover, symptom increase was associated with an ATD-induced decrease in testosterone 
in the MDD+A group but not the MDD-A group. ATD did not affect anger nor cortisol levels 
in either group, nor in the two groups combined (Chapter 4). No differences were found 
between MDD+A and MDD-A with respect to the effect of ATD on emotion processing or 
impulsivity (Chapter 5). 
Integration of the main findings
Subtype or severity marker?
A subtype of depression can be described based on a number of very different characteristics 
or combinations of characteristics. These can be clinical or biological features, as long as 
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the subtype is clinically meaningful in the sense that it informs treatment and/or predicts 
prognosis.
Our results described in Chapter 2 are similar to findings from previous studies; irritable 
depressed patients had higher levels of comorbid anxiety as was also reported by Fava et 
al. (2009) and they reported more loneliness and more suicide attempts (similar to Perlis 
et al., 2009). Depression with comorbid anxiety disorder is associated with earlier onset of 
MDD (Fava et al., 2000a) and a relatively and persistently higher level of depressive symptoms 
(Sherbourne and Wells, 1997). Depressed patients with comorbid anxiety disorder are at 
greater risk to quit treatment prematurely (Brown et al., 1996). Although both interpersonal 
psychotherapy and pharmacotherapy were shown to be effective for depression with and 
without comorbid generalized anxiety disorder (GAD), depressed patients with comorbid 
GAD took longer to recover (Brown et al., 1996). A third group of patients with depression and 
comorbid panic disorder showed poor recovery on both aforementioned therapies compared 
to depressed patients with and without comorbid GAD (Brown et al., 1996). Suicidality in 
MDD is also associated with slower recovery (Overholser et al., 1987, Wardenaar et al., 2014). 
In terms of personality traits, we found lower scores on Agreeableness and higher scores on 
Neuroticism in irritable depressed patients. With Agreeableness reflecting the maintenance 
of positive relations with others (Finch and Graziano, 2001) and Neuroticism reflecting a 
tendency towards negative mood states (Costa and Mccrae, 1980), the scores we found seem 
to indicate less favorable personality characteristics in irritable depressed patients compared 
to non-irritable depressed patients. High Neuroticism scores have previously been shown to 
strongly predict not only new-onset of but also lifetime MDD (Kendler et al., 2006). Moreover, 
lower Neuroticism scores have been associated with worse treatment outcome (Kennedy et 
al., 2005, Mulder, 2002).
Taken together, irritable depressed patients are characterized by more comorbid anxiety and 
higher risk of suicide. Combined with higher levels of loneliness and less favorable personality 
characteristics, irritable depressed patients seem to have a more disadvantageous clinical 
profile compared to non-irritable depressed patients. Such a profile may adversely affect speed 
of recovery and response to treatment.
Definition of depression subtypes has not only focused on behavioral characterization. 
Moreover, previous studies had found biological differences between depression with and 
without anger regulation problems (Iosifescu et al., 2007, Fava et al., 2000b, Dougherty et al., 
2004). Therefore, we also investigated biological correlates of anger regulation problems in 
this thesis. We found lower levels of cholesterol in irritable depressed patients compared to 
non-irritable patients (Chapter 2), although this difference was no longer significant after the 
inclusion of several covariates, such as depression severity. Hence, it seems that our findings 
Thesis.indd   123 05-10-14   23:37
124
for cholesterol are possibly explained by the difference in depression severity between the 
irritable and non-irritable depressed group, although there is little previous literature to 
support this.
We found no differences between irritable and non-irritable depressed patients on measures 
of HRV or cortisol.
To experimentally investigate whether remitted depressed patients with anger regulation 
problems during their depression have greater 5-HT impairments than remitted depressed 
patients without these problems during their depression, we applied ATD in a group of 
remitted depressed patients to investigate the difference in 5-HTergic function between 
depression with (MDD+A) and without (MDD-A) anger regulation problems. In Chapter 
3, the MDD+A group is shown to express greater 5-HTergic reactivity by showing a more 
pronounced symptom-response to high dose ATD compared to the MDD-A group. We 
also found a decrease in testosterone levels after high dose (but not low dose) ATD for the 
MDD+A group (Chapter 3) relative to the MDD-A group. This is consistent with diminished 
testosterone levels previously observed in depression (Zarrouf et al., 2009, Giltay et al., 2012). 
This finding may suggest that depression and testosterone are associated through 5-HTergic 
mechanisms, with greater 5-HT impairments in the MDD+A group compared to the MDD-A 
group, causing a larger decrease in testosterone levels in the former.
On the other hand, no differences between the MDD+A group and MDD-A group were 
found on the cognitive tasks; not on impulsivity, nor on emotion processing (Chapter 4). It 
seems that a possible subtype of depression characterized by anger regulation problems does 
not extend to the 5-HT/depression related areas of cognition we investigated.
Genetic influences may contribute to the development of depression (Kendler et al., 2001, 
Sullivan et al., 2000) as well as aggression (Gonda et al., 2011, Antypa et al., 2012, Coccaro et al., 
1997). MAOA genotypic variation has previously been associated with aggression (Brunner et 
al., 1993), particularly in association with maltreatment (Caspi et al., 2002, Foley et al., 2004, 
Huang et al., 2004, Kim-Cohen et al., 2006, Nilsson et al., 2006, Cicchetti et al., 2007, Enoch 
et al., 2010), although not consistently (Young et al., 2006, Alia-Klein et al., 2008). Compared 
to prior research, our study is novel in using outcomes measures that do not only include trait 
aggression and state aggression, but also reactivity of aggression to changes in mood state. 
We found that women with the high expressing variant of the MAOA gene (MAOA-H) had 
higher aggression reactivity scores than women with the low expressing variant (MAOA-L). 
These results of increased aggression reactivity in women were not found for men, nor were 
there any associations with childhood trauma. However, our study sample consisted of college 
students and trauma scores were relatively low.
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Our results do suggest that the association between the MAOA genotype and aggression 
depends on the context of the aggression, and differs between men and women. At least in 
this non-depressed student sample, vulnerability to aggression regulation problems may 
depend at least partly on genetic variation and sex which is reflected by reactivity of aggressive 
behaviors/thoughts. The observation that MAOA genotypic variation seems to affect mood-
dependent aggression but not state or trait aggression deserves further exploration in future 
studies including in clinical samples. A recent study showed that the impact of MAOA 
genotype in the context of adversity is age-dependent (Pingault, 2013). This finding also 
supports the need for longitudinal investigations.
Previously established subtypes of depression that have been used in clinical practice include 
melancholic and atypical depression. A study by Lamers et al. (2010) used data-driven analysis 
methods and identified subclasses of depression very similar to melancholic and atypical 
depression: one severe, melancholic class (with e.g. decreased appetite, weight loss, and early 
morning awakening) (46.3 % of the sample), a second severe, atypical class (symptoms e.g. 
increased appetite, weight gain, and leaden paralysis) (24.6 % of the sample) and a third class 
with moderate depression (29.1 % of the sample). Lamers’ subclasses were also characterized 
by significant symptomatic and biological differences, with more smokers and childhood 
trauma in the melancholic class and higher body mass index (BMI) and higher prevalence 
of metabolic syndrome in the atypical class. The moderately depressed class discerned itself 
from the others with significantly less depressive symptoms, less comorbid disorders, and 
better psychosocial functioning. On average these classes showed 76% stability on a two-year 
follow-up measurement (Lamers et al., 2012). The severe atypical and severe melancholic 
patients also differed on biological measures: the atypical subclass had significantly higher 
levels of inflammatory markers, larger waist circumference, and higher BMI as well as higher 
levels of metabolic syndrome markers. The melancholic subclass had higher cortisol levels. 
Differential treatment strategies of antidepressant prescription for the aforementioned 
classes have been in use for quite some time. Atypical depression has been found to respond 
better to monoamine oxidase inhibitors (MAOIs) (Quitkin et al., 1993, Liebowitz et al., 
1988, Nierenberg et al., 1998) than to tricyclic antidepressants (TCAs), whereas melancholic 
depression responds better to TCAs and serotonin reuptake inhibitors (SSRIs) (Hirschfeld, 
1999).
Besides melancholic and atypical depression, another well-established subtype of depression 
that responds well to specific treatment is Seasonal Affective Disorder (SAD). In most 
patients, SAD occurs in autumn and winter, subsiding with the increase of daylight-hours 
in spring and summer (Lurie et al., 2006). Treatment with light therapy has been found the 
preferred treatment of choice long ago (Rosenthal et al., 1984), with better results compared 
to fluoxetine (Ruhrmann et al., 1998).
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In the latest version of the DSM, the DSM-5, a new mood disorder has been introduced called 
disruptive mood dysregulation disorder (DMDD; American Psychiatric Association, 2013), 
which at first glance is not unlike the anger regulation problems under investigation in this 
thesis. Diagnostic criteria for this disorder include severe and recurrent temper outbursts 
which are inappropriate for the situation and which have been present for at least 12 months, 
occurring as frequent as three times a week. Mood between outbursts should be persistently 
irritable or angry. However, DMDD differs from the anger regulation problems explored in 
this thesis in that its diagnostic criteria dictate that the outbursts should not exclusively occur 
during an episode of major depression. Moreover, DMDD cannot be diagnosed in children 
younger than 6 years or adults (i.e. older than 18 years) and must be observed before the age 
of 10, whereas in the current thesis we only focused on adults. The addition of DMDD to the 
DSM-5 was controversial (Copeland et al., 2013, Parens et al., 2010, Stringaris, 2011). The 
rationale to include a new disorder mainly based on the extended presence of irritability and 
temper outbursts may have been the prevention of increasing diagnosis of bipolar disorder in 
children, especially in the US (Stringaris, 2011). However, Stringaris (2011) also emphasized 
that DMDD needs to be studied more extensively for it to be meaningful in clinical practice, 
e.g. its overlap with other disorders such as bipolar disorder and attention deficit hyperactivity 
disorder (ADHD) (Stringaris, 2011). The first studies on this newly classified disorder have 
only been published recently (e.g. Copeland et al., 2013, Dougherty et al., 2014). These studies 
both investigated community samples and found 3-month prevalence rates between 0.8% and 
8.2% with the highest rates in preschoolers to 6-year olds. Both studies found high frequencies 
of comorbid psychiatric disorders in those with DMDD. Another study suggested that 
children with parents with bipolar disorder are more often diagnosed with DMDD (Sparks et 
al., 2014), suggesting that DMDD may be a precursor of bipolar disorder.
Not only are the aforementioned subtypes distinguished by a distinct symptom or set of 
symptoms, most of them (i.e. melancholic and atypical depression, SAD) also differentiate 
on preferred treatment strategy. Can a putative subtype of depression characterized by anger 
regulation problems be distinguished? Chapter 2 shows that irritable depressed patients 
are characterized by a more disadvantageous set of symptoms including higher rates of 
comorbid anxiety, higher suicide risk and less favorable personality characteristics. We 
found some biological differences between depression with and without anger regulation 
problems; although we did not find differences on cortisol, cholesterol and HRV (Chapter 
2), we did find a difference in testosterone reaction to ATD between remitted depressed 
patients with and without anger regulation problems during their depression (Chapter 3). 
More importantly, those with anger regulation problems during their depression showed a 
greater mood response to high dose ATD (Chapter 3). Combining this greater mood reaction 
to ATD with the less advantageous symptom/personality profile found in Chapter 2, anger 
regulation problems seem to signify a more disadvantageous and possibly more severe form 
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of depression. The question whether it is possible to signify a subtype of depression only based 
on greater severity remains to be answered however.
Methodological Considerations and Limitations 
In the current thesis, anger regulation problems were operationalized in various ways. We 
have investigated irritability (‘feeling irritable more than half of the time’ to ‘feeling extremely 
irritable nearly all of the time’), but also anger (defined by persistent or repetitive thoughts and 
feelings of anger during the depressive episodes and at least one example of angry behavior 
such as yelling, throwing things or physically attacking others). In Chapter 5, we measured 
anger regulation problems more indirectly by means of aggression during an episode of mild 
dysphoria, with questions regarding thoughts of aggression and behavior such as losing 
one’s temper. Other studies have investigated hostility (Bagby et al., 1997) and suicidal 
ideation (Booij et al., 2006). As already explained in the introduction of this thesis (Chapter 
1), aggressive thoughts and behaviors in the context of depression have been observed for 
a long time; Freud already signified acts of suicidality (Freud, 1917) as depression turned 
inwards, which results in aggression towards oneself, and Kraepelin even mentioned murder 
(Kraepelin, 1883), especially towards loved ones, as an extreme example of aggressive behavior 
during depression. It remains to be investigated whether irritability and anger attacks as well 
as suicidality and murder in the context of depression signify the same problems, or originate 
from different mechanisms altogether.
In addition to the methodological limitations already discussed in chapters 2 to 5 of this 
thesis, is the sample of remitted depressed patients described in chapters 4 and 5. This sample 
is rather heterogeneous, especially in terms of current use of medication. Several studies 
found differences in reaction to ATD between patients on different antidepressants such as 
5-HTergic and noradrenergic medication (Delgado et al., 1999). However, a reanalysis of 
several ATD studies showed that sex and previous suicidal ideation were better predictors 
of the effect of ATD than use of antidepressant medication (Booij et al., 2002). Moreover, in 
our current sample, we did not find differences in medication use between the MDD+A and 
MDD-A group. Nevertheless, it would be of interest to replicate the findings in unmedicated 
patients, or in samples in which medication is randomized.
Another thing to be considered is the method of ATD used in the current study. The method 
of ATD used in the current study compares a full dose (100% or high dose) of the amino 
acid mixture used to lower tryptophan to a mixture containing 25% of the same mixture 
(low dose). The pros and cons of this design compared to the often used amino acid mixture 
containing Trp as a placebo condition have been discussed previously (Booij et al., 2006, 
Booij et al., 2005a, Merens et al., 2008). The alternative for the low dose ATD mixture is 
a mixture containing tryptophan. This method sometimes causes a rise of total tryptophan 
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levels (between 10% and 500%) (Klaassen et al., 1999, Weltzin et al., 1994), which may affect 
outcome measures such as depressive symptoms and cognition (Merens et al., 2008, Markus 
et al., 1998, Schruers et al., 2000). On the other hand, high dose and low dose ATD do not 
just differ in the degree to which they lower Trp levels but also lower the other amino acids 
to a different degree. Hence, both control measures have their own pros and cons. Therefore, 
it may be of interest to investigate both the ATD method used in this thesis and the ATD 
methods described above and compare possible outcome differences. Lastly, the observation 
that the effect of high dose ATD on depressive symptoms differs between men and women 
(Walderhaug et al., 2007, Booij et al., 2005b) is consistent with the observation from positron 
emission tomography (PET) studies of lower 5-HT synthesis rates in females than in males 
(Nishizawa, 1997). These findings have to be taken into account when interpreting results 
of the current study. Women have a more pronounced depressive response to ATD (Booij 
et al., 2002). However, in the current thesis we conducted separate analyses of co-variance 
(ANCOVAs) for differences between men and women, with sex as a covariate and we found 
no effect of sex on hormonal measures (testosterone and cortisol) or cognition, nor were 




The current thesis did not find differences between MDD+A and MDD-A patients on tasks 
measuring impulsivity and emotion processing. However, previous research combined with 
results from the current thesis does suggest differences between depression with and without 
anger regulation problems, both clinically and biologically. Whereas the current ATD study 
did not show aggression or other cognitive changes in reaction to high dose ATD, a previous 
study (Bjork et al., 2000) did show increased aggression in reaction to ATD in aggression-prone 
but not non-aggression-prone men during an anger provocation task, in which they were 
provoked by having money taken from them during a game. Another study showed increased 
feelings of anger accompanied by increased regional cerebral blood flow (rCBF) in anterior 
paralimbic regions of the brain after inducing anger in healthy men, using autobiographical 
narrative scripts of anger provoking situations (Dougherty et al., 1999). Future experimental 
studies could possibly benefit not only from inducing sad mood, e.g. by lowering 5-HT as 
was done in our ATD study, but by additionally using a provocation task such as an anger 
provocation task, or in the context of stressors, such as laboratory stress induction paradigms. 
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Brain imaging
Another option for future research would be to further investigate 5-HT neurotransmission 
in specific brain regions involved in emotion regulation and cognition, using imaging 
methods such as PET or functional magnetic resonance imaging (fMRI). Expanding on the 
studies by Bjork et al. (2000) and Dougherty et al. (2004, 1999) in healthy individuals using 
anger induction paradigms, a next step in the investigation of neural processes could be the 
inclusion of (remitted) depressed patients with and without anger regulation problems. This 
could shed some light on in brain regions involved in anger regulation problems in depression. 
(Epi)genetics
In Chapter 5, we investigated the role of putative genetic factors associated with aggression in 
a sample of college students. A next step could be the exploration of this genotype in relation 
to cognitive reactivity in irritable depressed patients and the interaction with life events. 
Expanding on this, follow-up studies could identify women with this specific genetic variant 
at baseline and follow them for several years to identify long term risks of this genetic variant, 
as well as other risk factors such as childhood maltreatment. Since childhood maltreatment 
scores were generally low in our sample of college students, including a larger sample of 
maltreated participants would be of interest for future studies.
It would also be of interest to study the underlying molecular mechanisms of aforementioned 
gene by environment interactions, e.g. by studying DNA methylation processes in specific 
5-HT genes (Booij et al., 2013, Wang et al., 2012).
Treatment
As mentioned in Chapter 1, previous research suggests SSRIs may be useful in treating 
depression with anger regulation problems. The current thesis did not include randomized 
controlled trials (RCTs) on the use of 5-HTergic antidepressants to treat depression with 
anger regulation problems, making it something to be considered for future studies. Not only 
SSRIs would be of interest for future research, but also the use of Trp to increase brain 5-HT. 
A study by Aan het Rot et al. (2006) showed significant reductions of quarrelsome behaviors 
and significantly increased agreeableness in healthy individuals after 15 days of Trp compared 
to placebo.
Although we cannot draw conclusions about treatment preferences for depression with anger 
regulation problems based on the current thesis or on previous studies, it may be useful to 
include this symptom in the diagnostics of depression, since it does signify greater depression 
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severity. The need to recognize all aspects that could influence depression and its treatment 
ties in with the concept of staging and profiling.
In other areas of medicine, e.g. oncology, the concepts of staging and profiling are used to 
facilitate diagnosis and treatment (Huijgens, 2012). Staging is the description of the stage of 
development a disease is in; profiling is the recognition of factors influencing course of and 
reaction to treatment (Kapczinski et al., 2009). The idea of introducing staging in psychiatry 
was already suggested by Fava and Kellner (Fava and Kellner, 1993); however, psychosis is the 
only psychiatric illness in which this construct has been applied completely and successfully 
so far (Hetrick et al., 2008). That being said, the Multidisciplinary Guideline for depression 
(Spijker et al., 2013) does take into account a rough estimate of the stage of the depression 
(duration shorter or longer than 3 months, first/recurrent episode) and some specific 
symptoms (suicidality, psychosis, melancholic features) are taken into account in treatment 
decisions. This could be expanded: placing a person on a continuum of the course of illness, 
recognizing not only full-blown or even severe stages of the disease, but also vulnerability 
factors such as family history and prodromal phase of the disease. Some evidence has been 
found that interventions are more beneficial when used earlier (Kupfer et al., 1989) and it 
has been suggested that detection of subclinical depression should be seriously considered 
for (early) intervention and/or treatment (Kessler et al., 1997). Early detection would also 
decrease the burden of the disease on patients (Feightner and Worrall, 1990a, Feightner and 
Worrall, 1990b). Early recognition of higher severity of a depressive disorder may call for more 
intensive treatment options, e.g. combining psychopharmacology with cognitive behavioral 
therapy (De Jonghe et al., 2001, Oestergaard and Moldrup, 2011, Cuijpers et al., 2009).
As mentioned before, the DSM-5 contains a newly classified depressive disorder based on 
temper outbursts and aggression called DMDD. Future studies may take this new DSM-
5 diagnosis into account when investigating anger regulation problems in the context of 
depression, and investigate its relation to anger regulation problems in adult depression 
as has been investigated by the current thesis. A previous study on irritability in children 
had already shown that irritability in adolescents is a predictor of depression and anxiety 
in later life (Stringaris et al., 2009). The question remains whether DMDD is a precursor 
to or childhood version of irritable/angry depression in adults, or possibly bipolar disorder 
(Sparks et al., 2014). Other studies have also suggested that irritability is may be a feature of 
unrecognized bipolar (spectrum) disorder (Benazzi, 2003, 2010, Benazzi and Akiskal, 2005).
Investigation into this question may eventually contribute to improved recognition of the 
different stages of depression.
In addition, more extensive profiling could help recognize aspects of depression that predict 
outcome and treatment response, much like the current labeling of subtypes has been doing, 
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but taking into account all possible levels of characterization. Ranging from personality and 
reactivity profiles to biological profiles which are not restricted to 5-HT, but include dopamine 
(Tye et al., 2012) and noradrenaline (Haenisch and Bönisch, 2011) as well, the identification 
of additional characteristics of depression can help create a more complete profile of the 
disease and may thus contribute to better treatment choice.
Conclusion
The current thesis aimed at investigating the significance of anger regulation problems in 
depression. One of the aims was to investigate to which extent these problems represent a 
subtype of depression. This thesis suggests that anger regulation problems during depression 
signify a more severe form of depression. Previous studies suggest pharmacotherapy, more 
specifically SSRIs, as the treatment of choice for depression with anger regulation problems. 
RCT studies on the use of SSRIs and Trp could shed further light on the use of 5-HTergic 
antidepressants in the treatment of depression with anger regulation problems.
The identification of a specific profile of depression characterized by anger regulation problems 
may strengthen the idea that research should focus on staging and profiling of depression, 
identifying factors that contribute to severity of the disease require specific treatment.
The relationship of the currently discussed profile of anger regulation problems in depression 
with DMDD is another topic that needs to be investigated; is DMDD a precursor of or 
childhood version of anger regulation problems in depression in adults? Or is it related to 
bipolar disorder in later life? 
Moreover, future research could include brain imaging studies to further quantify the 
specificity of the profile as well as anger induction paradigms to provoke differences between 
patients with and without anger regulation problems during their depression. Longitudinal 
research could contribute to the recognition of risk factors for this specific depression 
profile as well as precursors in childhood and adolescence, while DNA methylation research 
might shed light on how gene and environment physiologically interact. Taken together, 
multidisciplinary research into this subject should integrate several areas of expertise in order 
to fully determine the role of anger regulation problems in depression and specifically focus 
on how to implement findings in clinical practice.
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Maar liefst 15,4% van de Nederlanders heeft op enig moment in hun leven last van depressieve 
klachten. Hoewel er sinds het ontstaan van de diagnose ‘depressie’ veel onderzoek naar deze 
aandoening is gedaan, en er vele behandelingsvormen mogelijk zijn, is herstel vaak een 
langdurig en intensief proces. Daarnaast blijft volledig of gedeeltelijk herstel voor sommige 
patiënten zelfs uit.
De diagnose ‘depressie’ omvat een grote verscheidenheid aan patiënten. Dit komt doordat de 
diagnose depressie gesteld wordt op basis van de aanwezigheid van vijf van elf beschreven 
criteria of symptomen. Het gevolg is dat twee patiënten, die vijf volledig verschillende 
symptomen rapporteren, toch dezelfde diagnose ‘depressie’ krijgen. Door deze verscheidenheid 
is het moeilijk gebleken om snel de juiste behandeling voor een individuele patiënt te vinden. 
Om de verscheidenheid te verminderen en behandelkeuzes doeltreffender te maken, wordt 
als sinds het ontstaan van de depressiediagnose gezocht naar relevante subtyperingen van 
depressie.
De relatie tussen depressie en boosheid werd al gelegd door Kraepelin en Freud, aan het eind 
van de 19e en begin van de 20e eeuw. In de jaren ’90 van de 20e eeuw nam de interesse in 
deze relatie toe. De Nederlandse professor Dr.van Praag suggereerde dat een combinatie van 
angstsymptomen met boosheid en/of woedeaanvallen een subtype van depressie kenmerkte, 
en dat deze symptomen veroorzaakt werden door een verstoring van het serotonine-niveau. 
Behandeling met antidepressiva die invloed hebben op het op het serotonine systeem zouden 
de klachten snel en effectief verlichten, zo beargumenteerde van Praag. Onderzoekers uit 
Boston, waaronder professor Dr. Fava en Dr. Perlis, definieerden dit mogelijke subtype verder 
en noemden het ‘depressie met woedeaanvallen’, waarbij een woedeaanval werd gedefinieerd als 
plotseling opkomende woede, die gepaard gaat met symptomen van autonome activatie zoals 
hartkloppingen en zweten, zoals die bij een paniekaanval worden waargenomen, maar zonder 
de voor een paniekaanval kenmerkende gevoelens van angst. Experimentele studies naar dit 
subtype vonden dat depressieve patiënten die last hadden van dergelijke woedeaanvallen 
een hogere mate van vijandigheid lieten zien, maar ze waren ook angstiger dan depressieve 
patiënten zonder woedeaanvallen. Daarnaast verschilden de twee groepen fysiologisch van 
elkaar: depressieve patiënten met woedeaanvallen hadden een hoger cholesterolgehalte en 
een verhoogd risico op hartfalen.
De onderzoekers in Boston vergeleken niet alleen depressieve patiënten met en zonder 
woedeaanvallen, maar ze onderzochten ook een mildere vorm van boosheid, namelijk 
prikkelbaarheid. Uit het onderzoek bleek dat prikkelbare depressieve patiënten naast hun 
depressie vaker ook een angststoornis hadden dan niet-prikkelbare depressieve patiënten. 
Tevens hadden prikkelbare depressieve patiënten vaker een zelfmoordpoging gedaan.
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In dit proefschrift wordt dieper ingegaan op de relevantie van boosheid in de context van 
depressie; verschillen depressieve patiënten met en zonder boosheid klinisch van elkaar, 
maar ook bijvoorbeeld ook op het gebied van cognitie en serotonerge kwetsbaarheid? Kan 
inderdaad gesproken worden van een subtype van depressie gekenmerkt door boosheid?
In hoofdstuk 2 is gebruik gemaakt van data uit de Nederlandse Studie naar Depressie en Angst 
(NESDA) om prikkelbare en niet-prikkelbare depressieve patiënten met elkaar te vergelijken.
46% van de 913 geselecteerde depressieve patiënten had last van een redelijke tot hoge mate 
van prikkelbaarheid. Deze prikkelbare depressieve patiënten scoorden bovendien hoger 
op depressie-ernst, angst, hypomane symptomen en zij hadden meer last van gedachten 
gerelateerd aan agressie in reactie op een sombere stemming (ook wel: cognitieve reactiviteit 
van agressie), waarbij boosheid als een afgeleide van agressie kan worden gezien. De 
prikkelbare depressieve patiënten verschilden echter niet van niet-prikkelbare depressieve 
patiënten op fysiologische parameters, zoals cortisol, cholesterol en hartritmevariabiliteit, 
ook niet na correctie voor de ernst van de depressie. Ook op langere termijn, namelijk na 
een jaar, werden vergelijkbare verschillen gevonden tussen prikkelbare en niet-prikkelbare 
depressieve patiënten.
Erfelijkheid lijkt een belangrijke rol te spelen bij het ontstaan en voortduren van 
psychopathologie. De erfelijkheid van depressie en agressieis reeds uitgebreid bestudeerd. 
Er is echter weinig bekend over de erfelijkheid van boosheid gerelateerd aan depressie. 
In hoofdstuk 3 werd een genetisch mechanisme onderzocht dat mogelijk geassocieerd is 
met boosheid bij depressie. Het onderzoek richtte zich met name op de relatie tussen de 
genotypische variatie van Monoamine Oxidase A (MAOA) en boosheid en de al eerder 
onderzochte interactie met jeugdtrauma. Om de rol van het MAOA-gen bij boosheid 
bij depressie te onderzoeken, werd getoetst of de lage expressie variant van dit gen o.a. 
geassocieerd is met verschillende maten van boosheid (situatie-specifiek of ‘state’ versus 
persoonlijkheidstrek of ‘trait’). Daarnaast werd de cognitieve reactiviteit van patiënten 
gemeten: dit is de mate waarin negatieve denkpatronen geactiveerd worden op het moment 
dat iemand somber is. In totaal werden van 432 West-Europese studenten DNA afgenomen 
en het genotype bepaald van het MAOA-LPR polymorfisme voor het MAOA-gen. Het 
MAOA-genotype bevindt zicht op het X chromosoom, waarbij een onderscheid kan worden 
gemaakt tussen efficiëntere (H-allel) en minder efficiënte (L-allel) allelen. Deelnemers vulden 
tevens vragenlijsten in over jeugdtrauma, boosheid en cognitieve reactiviteit. Vrouwen met 
het MAOA-H allel hadden hogere agressie reactiviteit scores dan vrouwen met het MAOA-L 
allel. Dit effect werd niet gevonden bij mannen, hoewel de niet-significante bevindingen bij 
mannen mogelijk het gevolg van de relatief kleine groep zijn. Er werden ook geen effecten 
van de MAOA genvariant gevonden op boosheid, of interacties van MAOA genvariant met 
jeugdtrauma. Een beschermend effect van de lage-expressie variant van het MAOA-gen bij 
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vrouwen op cognitieve reactiviteit van agressie werd eerder al gevonden in tienermeisjes. 
Het onderzoek beschreven in dit proefschrift geeft aan dat vrouwen met het MAOA-H allel 
wellicht gevoeliger zijn voor boosheid of agressie wanneer ze in een sombere stemming zijn.
Zowel depressie als agressie zijn eerder in verband gebracht met verminderde serotonine-
overdracht. Een volgende stap was dan ook het onderzoeken van serotonerge kwetsbaarheid 
bij boosheid in depressieve patiënten. Door gebruik te maken van acute tryptofaandepletie 
(ATD) werd onderzocht of herstellende depressieve patiënten met boosheid tijdens hun 
depressie meer beperkingen in het serotonine systeem hebben, in vergelijking met herstellende 
depressieve patiënten zonder boosheid tijdens hun depressieve episode. In hoofdstuk 4 en 
hoofdstuk 5 wordt ingegaan op de resultaten van dit experimentele onderzoek. Voor dit 
onderzoek namen 26 herstelde depressieve patiënten met en zonder boosheid tijdens hun 
depressie deel aan een ATD-studie. Voor deze studie kregen alle deelnemers zowel een hoge 
als een lage dosering ATD, waarbij zowel de deelnemers als de onderzoekers niet wisten welke 
dosering op welke testdag genomen werd. De lage dosering bevat 25% van de hoeveelheid die 
gebruikt wordt in de hoge dosering. Eerder onderzoek met deze methode heeft aangetoond 
dat de lage dosering geen effect heeft op stemming en cognitie, terwijl dit bij de hoge dosering 
wel het geval is.
In hoofdstuk 4 wordt ingegaan op de verschillen tussen de deelnemers met en zonder 
boosheid tijdens hun depressie in reactie op ATD. Tevens werd in het onderzoek ingegaan 
op de het effect van ATD op veranderingen van testosteron en cortisolniveaus. Deze twee 
hormonen zijn betrokken bij zowel depressie als boosheid. De ATD zorgde na 7 uur voor 
een tijdelijke toename van depressieve symptomen alsmede een afname van het testosteron 
niveau bij de deelnemers. De stemmingsreactie na ATD was groter in de groep patiënten met 
boosheid tijdens de depressie dan in de groep zonder boosheid. Deze toename van depressieve 
stemming hing samen met de afname van het testosteronniveau. Boosheid en cortisol-niveau 
veranderden niet door ATD. Het lijkt er dus op dat depressieve patiënten met boosheid een 
grotere verstoring van het serotoninesysteem hebben dan depressieve patiënten zonder 
boosheid, waardoor ze sterker reageren op ATD. Bovendien suggereren de bevindingen in 
hoofdstuk 4 dat depressie en testosteron verbonden zijn via serotonerge mechanismen. In 
hoofdstuk 5 werden verschillen in cognitie tussen herstelde depressieve patiënten met en 
zonder boosheid tijdens hun depressie onderzocht, waarbij gekeken werd of bij depressie 
met boosheid ook sprake is van een verhoogde mate van impulsiviteit in vergelijking met 
de MDD-A groep. Bovendien werd onderzocht of boosheid bij depressie de herkenning 
van en de reactiesnelheid op emotionele gezichtsuitdrukkingen beïnvloedt. Wat betreft de 
impulsiviteitstaak werd een afname van het onderscheidingsvermogen tussen stimuli na een 
lage dosis ATD voor alle deelnemers gevonden, maar verder geen wezenlijke veranderingen 
in impulsiviteit, reactietijden of onderscheidingsvermogen van de aangeboden stimuli na een 
hoge dosis ATD. Er werden geen verschillen in impulsiviteit tussen de groep met en zonder 
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boosheid tijdens hun depressie gevonden. Daarnaast werden ook geen verschillen gevonden 
in reactie op de ATD methode tussen de twee groepen. De gezichtsherkenningstaken lieten 
geen van beiden significante effecten zien; niet van ATD voor de totale groep deelnemers, 
noch voor de groepen afzonderlijk of voor een interactie tussen groep en ATD-dosering.
Hoofdstuk 6 omvat een samenvatting van de hoofdstukken 2 tot en met 5 en een algemene 
bespreking van de studies in dit proefschrift.
De studies in dit proefschrift suggereren dat er bij boosheid tijdens een depressie vooral 
sprake is van een ernstigere mate van depressie, waarbij meer symptomen voorkomen, vaker 
een comorbide angststoornis wordt vastgesteld en een grotere kans op suïcidaliteit bestaat. 
Tevens verschilt depressie met boosheid van depressie zonder boosheid op fysiologische 
maten zoals testosteron en cholsterol. Zo bezien draagt het vaststellen van een depressieprofiel 
met boosheid als specifiek kenmerk bij aan de idee dat onderzoek zich moet gaan richten 
op stagering en profilering van depressie: het identificeren van factoren die bijdragen aan 
de ernst van de depressie en die specifieke behandeling vereisen. Vervolgonderzoek naar 
boosheid bij depressie zou zich dan ook verder kunnen richten op de beste behandelstrategie. 
Toekomstig onderzoek naar depressie met boosheid kan verder aangevuld worden met 
hersenonderzoek met behulp van beeldtechnieken; zijn er wellicht verschillen in anatomie en 
neurale activatiteit van de hersenen tussen depressieve patiënten met en zonder boosheid? Een 
aanvulling op de ATD studie beschreven in hoofdstuk 4 en 5 kan bestaan uit de toevoeging 
van boosheidinductie, oftewel een experiment, waarin boosheid wordt uitgelokt door middel 
van een frustrerende taak of het denken aan een situatie waarin men boos was. Wellicht 
komen cognitieve (en andere) verschillen tussen patiënten met en zonder boosheid tijdens 
hun depressie dan alsnog aan het licht.
In de nieuwste versie van de ‘Diagnostic and Statistical Manual of Mental Disorders’ (DSM), 
de DSM-5, staat een nieuwe stemmingsstoornis beschreven die gekenmerkt wordt door 
regelmatige woedeuitbarstingen genaamd ‘disruptive mood dysregulation disorder’ (DMDD). 
Deze woedeuitbarstingen zijn echter niet exclusief aanwezig tijdens depressieve episodes. 
Bovendien kan de diagnose niet gesteld worden na het 18e levensjaar. De relatie van het in dit 
proefschrift besproken profiel van boosheid bij depressie met DMDD is een ander onderwerp 
dat moet worden onderzocht; is DMDD gedurende de kindertijd een voorloper van boosheid 
bij depressie bij volwassenen? Is er een verband tussen DMDD en het voorkomen van een 
bipolaire stoornis in het latere leven? Om beter zicht te krijgen op de ontwikkeling van 
depressie met boosheid en mogelijke risicofactoren hiervoor, zoals DMDD in de kindertijd, is 
vervolgonderzoek nodig in de vorm van longitudinale studies. Onderzoek naar verandering in 
genetische expressie gedurende het leven, veroorzaakt door DNA-methylatie, kan vervolgens 
nieuw licht werpen op hoe deze risicofactoren vanuit de omgeving interacteren met genen en 
zo invloed hebben op de ontwikkeling van depressie met boosheid.
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Multidisciplinair onderzoek naar dit onderwerp kan een aantal expertisegebieden integreren, 
om zo te bepalen wat de rol van boosheid bij depressie inhoudt. Uiteindelijk zal dan duidelijk 
moeten worden hoe de verschillende resultaten een rol in de klinische praktijk en dus de 
behandeling van de patiënt kunnen spelen.
Thesis.indd   147 05-10-14   23:37
148
Thesis.indd   148 05-10-14   23:37
149
Dankwoord
Daar is ie dan: het snelst geschreven, en daardoor meest oprechte deel van dit proefschrift. 
Ik kan namelijk veel alleen, maar dit had ik nooit gekund zonder de hulp van een heleboel 
mensen.
Willem, wat heb ik veel van je geleerd. Met de lessen in precisie en nuance bij het schrijven 
heb ik nogal geworsteld, maar ergens ben ik toch bovengekomen, aan dit boekje te zien. 
Verdere lessen (in willekeurige volgorde): het drinken van koffie, het geven van presentaties 
en loyaliteit.
Linda, dank voor je immer snelle reacties, je eeuwige bereidheid om via Skype mijn ellenlange 
lijst met vragen te beantwoorden en bovenal: dankjewel dat je me de kans hebt gegeven naar 
Montréal te komen, het beste halfjaar van mijn promotietraject!
Dank aan de medewerkers van de afdelingen Psychiatrie en Anesthesiologie van het LUMC 
voor de ondersteuning tijdens het uitvoeren van het ATD-experiment. Dank ook aan Betsie 
van het priklab voor het leren bloedprikken in de praktijk. En enorm veel dank aan mijn 
arme proefpersonen, die zich vrijwillig twee dagen in een lab lieten opsluiten met als ontbijt 
het smerigste drankje ooit bedacht en een lunch van plakjes plastic die voor brood moesten 
doorgaan.
Irene de Nooy: kijk, een boekje! Dat is ook jouw verdienste, dankjewel!
Collega’s. Die van FSW in Leiden, en dan met name Jolijn, Niki (2B39 roomies) en Nathalie, 
Linda en Anne-Wil. Dankjulliewel, voor alles.
Collega’s in Groningen, ook jullie zijn niet verschoond gebleven van mijn ‘ei’-perikelen, maar 
zoals ik hier in Grun heb geleerd: Celebrate everything. Laten we dat blijven doen.
Dan. Kipjes. Eigenlijk zijn we wel toe aan een nieuwe titel, anderzijds: kan het ons lekker 
schelen wat mensen van onze Geuzennaam denken. Aline, Anne, Marieke, Marin: wij, 
begonnen als 5 promovendi, zo verschillend en steeds verspreid over verschillende steden, 
provincies en continenten. Dat er nog maar vele kipjesweekenden mogen volgen, met nieuwe 
én vertrouwde ingrediënten.
Haantjes (Marnix, Tim, Chun, Jasper, Gerard), jullie mag ik ook niet vergeten. Dankjulliewel 
voor hulp bij verhuizingen en andere (studenten)levensperikelen (waaronder de gejatte fiets 
die niet gejat bleek). Ook voor jullie geldt dat we vrienden blijven, waar ook ter wereld we 
terecht komen.
Kære Hannah, Thit, Jeppe, Carsten, Kirstine, Lap, Annabelle, og alle de andre fra det 
Middelaldercentret: i er mit hjem. I still need to work on my Danish tho...
Thesis.indd   149 05-10-14   23:37
150
Geachte paranimfen. Mike, van antagonist, naar docent, naar grote broer en vriend. Als 
paranimf heb jij geen sabel nodig, je maakt me altijd sterker.
Anne-Wil, soms heb ik meer gelijk dan jij, maar als het om wetenschap gaat nooit: ik hoop dat 
je nog lang mijn vraagbaak wilt zijn.
Thus, je bent de enige echte Brabo van ons drieën, en in je beroepskeuze ga je ook je eigen 
weg. Ik ben een stuk cooler met een DJ als broer. Merel, kleine zus, gelukkig promoveer ik 
toch nog net iets eerder dan jij, maar wat fijn dat je me kon helpen met de laatste loodjes.
Broertje en zusje, op de middelbare school zeiden ze het al (ze hadden namelijk nogal last van 
onze eigenwijsheid): wat lijken we ongelofelijk veel op elkaar!
Lieve pp&mm, behalve een belezen, kritische, rijke basis dank ik aan jullie ook mijn 
doorzettingsvermogen. Goed voorbeeld doet goed volgen, en ik zal altijd door die zure appel 
bijten. Dat proefschrift is er dankzij jullie!
Laurens. Sta je dan, op de cover. Meer dan ‘fietsbel’ hoef ik niet te zeggen toch?
Thesis.indd   150 05-10-14   23:37
151
Curriculum Vitae
Floor Verhoeven (12-12-1982) spent the first eighteen years of her life in Breda, the 
Netherlands. After graduating from the Onze Lieve Vrouwelyceum in 2001, she took a gap-
year before starting her BSc in Biological Psychology at the University of Maastricht in 2002. 
In 2007, she obtained her MSc in Neuropsychology at the same University after which she 
commenced her PhD research at Leiden University, under the supervision of Prof. Dr. Willem 
van der Does and Dr. Linda Booij.
Currently she works at the University Center for Psychiatry at the University Medical Center 
Groningen, as a post-doctoral researcher and a coordinator for the Northern Netherlands 
Network for Mood and Anxiety Disorders.
Thesis.indd   151 05-10-14   23:37
